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ABSTRACT	  	  
THESIS:	  Hemostatic	  Adaptations	  Following	  a	  High-­‐Intensity	  Interval	  Training	  Intervention	  in	  Healthy	  Men	  
STUDENT:	  James	  R.	  Sackett	  
DEGREE:	  Master	  of	  Science	  
COLLEGE:	  College	  of	  Applied	  Sciences	  and	  Technology	  
DEPARTMENT:	  School	  of	  Physical	  Education,	  Sport,	  and	  Exercise	  Science	  
DATE:	  May	  2015	  
PAGES:	  69	  	  High	   intensity	   interval	   training	   (HIIT)	   is	   a	  novel	  mode	  of	   exercise	   training	   that	  has	  been	  shown	   to	   improve	   several	   components	   of	   health	   in	   various	   healthy	   and	   diseased	  populations.	   	   Purpose:	   	   The	   purpose	   of	   the	   present	   study	   was	   to	   examine	   hemostatic	  adaptations	   in	   healthy	   adult	  men	   following	   four	   and	   eight	  weeks	   of	   a	  HIIT	   intervention.	  
Methods:	  Twenty-­‐one	  healthy	  but	  sedentary	  men	  (age:	  25	  ±	  5	  yrs;	  BMI:	  26.7	  ±	  6.2	  kg/m2)	  volunteered	   to	  participate	   in	   the	  present	   study.	   	   Subjects	   completed	   eight	  weeks	  of	  HIIT	  that	   included	   three	   to	   six	   ‘all	   out’	   Wingate	   tests	   three	   days/week.	   	   Overall	   blood	  coagulation	  was	  assessed	  at	  baseline,	   following	  four	  weeks,	  and	  following	  eight	  weeks	  by	  clotting	  times	  of	  activated	  partial	  thromboplastin	  time	  (APPT)	  and	  prothrombin	  time	  (PT),	  and	  plasma	  concentration	  of	  fibrinogen.	   	  Plasma	  was	  obtained	  from	  whole	  blood	  samples	  taken	  at	  rest.	   	  A	  repeated	  measures	  ANOVA	  was	  used	  to	  compare	  the	  overall	  coagulation	  potential.	  	  Significance	  was	  set	  to	  p	  <	  0.05.	  	  Results:	  There	  were	  no	  significant	  differences	  between	  resting	  heart	  rate,	  resting	  blood	  pressure,	  APTT	  (baseline:	  43.0	  ±	  5.4;	  4w:	  42.7	  ±	  
	  vii	  


















	  	   Although	   the	   existing	   body	   of	   knowledge	   and	   research	   on	   cardiovascular	   disease	  (CVD)	  has	  grown	  tremendously	  over	  the	  past	  several	  years,	  CVD	  remains	  the	  most	  common	  cause	  of	  death	  in	  the	  world	  today	  [1].	  	  A	  study	  by	  Murphy	  et	  al.	  showed	  that	  CVD	  or	  a	  CVD	  related	  event	  accounted	  for	  24.2%	  of	  the	  total	  deaths	  in	  2010	  [1].	   	  Several	  peer-­‐reviewed	  articles	  touch	  on	  how	  CVD	  and	  its	  predictors	  can	  be	  prevented,	  with	  the	  most	  common	  task	  being	  regular	  physical	  activity	  [[2,	  3].	   	   It	   is	  well	  known	  that	  exercising	  regularly	  will	  help	  prevent	  CVD	  and	  several	  CVD	  complications.	  	  
Exercise	  and	  Thrombosis	  The	   majority	   of	   cardiovascular	   events,	   including	   approximately	   80%	   of	   acute	  myocardial	   infarctions,	   are	   initiated	   by	   a	   blood	   clot,	   or	   thrombus,	   that	   occludes	   arterial	  blood	   flow	   [4].	   	   The	   ability	   of	   one’s	   blood	   to	   clot,	   or	   the	   coagulation	   potential,	   has	   been	  directly	   related	   to	   the	   onset	   of	   CVD	   as	   a	   thrombus	   may	   occur	   [5].	   	   The	   prediction	   of	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coronary	  risk	  can	  be	  determined	  by	  several	  factors	  (e.g.,	  Factor	  VIII	  [FVIII]	  and	  fibrinogen)	  as	   these	   factors	   may	   promote	   a	   procoagulant	   state	   of	   the	   hemostatic	   system	   [2].	   	   It	   is	  theorized	  that	  exercise	  training	  reduces	  one’s	  overall	  coagulation	  potential,	  as	  this	  is	  one	  of	  the	  reasons	  that	  regular	  exercise	  is	  cardioprotective.	  Standard	   exercise	   guidelines	   recommend	   150	   minutes	   per	   week	   of	   moderate-­‐intensity	  aerobic	  physical	  activity,	  typically	  occurring	  in	  20-­‐60	  minute	  bouts	  of	  continuous	  training,	   taking	   place	   3-­‐5	   days	   per	  week	   [6,	   7].	   	   Previously	   published	   studies	   utilize	   this	  recommendation	   from	   the	   American	   College	   of	   Sports	   Medicine	   but	   have	   produced	  inconsistent	  results	  with	  regard	  to	  coagulation	  potential	  [8-­‐11].	  	  Several	  modes	  of	  exercise	  training	   show	   an	   increased	   coagulation	   potential	   [12-­‐14],	   while	   others	   show	   a	   decrease	  [10,	  11,	  15]	  or	  no	  change	   in	  coagulation	  activity	   following	  training	  [16].	   	  These	  equivocal	  results	  related	  to	  exercise	   training	  support	   the	  need	   for	   further	   investigations	  of	   training	  regimens	  that	  may	  differ	  from	  traditional	  recommendations.	  
High-­‐Intensity	  Interval	  Training	  High-­‐intensity	  interval	  training	  (HIIT)	  involves	  short,	  intermittent	  bouts	  of	  vigorous	  physical	   activity,	   interspersed	   with	   brief	   periods	   of	   passive	   or	   low-­‐intensity	   active	  recovery.	  	  Common	  HIIT	  protocols	  utilize	  5-­‐30	  seconds	  of	  high-­‐intensity	  exercise,	  followed	  by	  a	  brief	  recovery	  period,	  repeated	  3-­‐6	  times.	  	  Various	  HIIT	  protocols	  have	  been	  shown	  to	  improve	  markers	  of	   aerobic	  physical	   fitness	   in	   various	  healthy	   and	  diseased	  populations	  [17-­‐21].	   	   Also,	   HIIT	   has	   been	   shown	   to	   improve	   endothelial	   function,	   resting	   blood	  pressure,	   and	   left	   ventricular	   morphology	   [17,	   20,	   22],	   each	   of	   which	   is	   related	   to	  coagulation	  potential	  [23-­‐25].	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Previous	   research	   indicates	   that	   the	  magnitude	   of	   coagulation	   responses	   to	   acute	  exercise	   are	   positively	   associated	  with	   intensity	   [26],	   leading	   to	   the	   speculation	   that	   the	  moderate	  intensities	  used	  in	  traditional	  exercise	  training	  may	  not	  stimulate	  the	  hemostatic	  system	  in	  such	  a	  way	  that	  would	  lead	  to	  beneficial	  changes	  in	  coagulation	  potential.	  	  Blood	  clotting	  adaptations	  following	  a	  HIIT	  regimen	  are	  unknown.	  
Statement	  of	  the	  Problem	  	   Clotting	  potential	  of	  one’s	  blood	  has	  been	  related	  to	  several	  adverse	  cardiovascular	  events	  [5].	   	  Furthermore,	  exercise	  training	  is	  expected	  to	  reduce	  one’s	  thrombotic	  risk	  by	  lowering	   overall	   coagulation	   potential	   [26,	   27].	   	   Despite	   the	   large	   body	   of	   evidence	  supporting	   the	   benefits	   of	   regular	   exercise	   and	   the	   known	   dose-­‐response	   relationship	  between	  activity	  and	  disease,	  there	  is	  no	  consensus	  regarding	  the	  required	  dose	  of	  exercise	  needed	  to	  promote	  desired	  physiological	  adaptations	  [28,	  29].	  
Specific	  Aims	  The	  specific	  aims	  of	  this	  study	  were:	  1) To	  determine	  whether	   healthy	   adults	   experience	   increased	   or	   decreased	   levels	   of	  FVIII	   and	   fibrinogen	   following	   four	   and	   eight	   weeks	   in	   an	   eight	   week	   HIIT	  intervention.	  2) To	   determine	   whether	   healthy	   adults	   experience	   increased	   or	   decreased	  prothrombin	  time	  (PT)	  and	  activated	  partial	  thromboplastin	  time	  (APTT)	  following	  four	  and	  eight	  weeks	  in	  an	  eight	  week	  HIIT	  intervention.	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Hypotheses	  It	   was	   hypothesized	   that	   sedentary,	   healthy	   men	   will	   experience	   a	   progressive	  decrease	   in	  FVIII	  and	   fibrinogen	   levels	  as	   training	  volume	   increases	   throughout	   the	  eight	  week	   HIIT	   intervention.	   	   It	   was	   also	   hypothesized	   that	   sedentary,	   healthy	   men	   will	  experience	   a	   progressive	   increase	   in	   clotting	   times	   throughout	   the	   eight	   week	   HIIT	  intervention.	  
Importance	  of	  the	  Study	  
	   There	   is	   controversy	   regarding	   the	   effect	   of	   traditional	   endurance	   training	   on	  hemostatic	  variables,	  especially	  those	  of	  coagulation	  potential.	   	  Understanding	  the	  proper	  dose-­‐response	   relationship	   of	   regular	   exercise	   training	   to	   promote	   desired	   physiological	  outcomes	  is	  important	  in	  both	  research	  and	  applied	  settings.	  	  However,	  the	  effects	  of	  a	  HIIT	  intervention	   on	   hemostatic	   variables	   have	   yet	   to	   be	   examined.	   	   The	   results	   from	   this	  research	   study	   will	   demonstrate	   novel	   and	   valuable	   findings	   to	   add	   to	   the	   scientific	  literature	   and	   yield	   a	   deeper	   understanding	   of	   exercise	   training	   adaptations	   on	   the	  hemostatic	  system.	  	  
Delimitations	  Twenty-­‐one	  non-­‐smoking	  men	  between	  18-­‐45	  years	  old	  volunteered	  for	  this	  study.	  	  Subjects	  were	  sedentary	  (less	  than	  two	  days,	  30	  minutes	  a	  day,	  of	  aerobic	  physical	  activity	  per	  week	  in	  the	  past	  three	  months)	  and	  free	  from	  any	  known	  cardiovascular	  or	  metabolic	  disease.	  	  Subjects	  also	  weighed	  more	  than	  50	  kg	  (110	  lbs)	  and	  had	  no	  physical	  limitations	  that	  would	  prevent	  them	  from	  doing	  strenuous	  anaerobic	  exercise.	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Subjects	   considered	   "high	   risk"	   according	   to	  American	   College	   of	   Sports	  Medicine	  guidelines	   were	   ineligible	   to	   participate.	   	   High	   risk	   was	   defined	   as	   any	   known	  cardiovascular,	  pulmonary,	  and/or	  metabolic	  disease	  as	  well	  as	  any	  of	  the	  following	  major	  signs	  or	   symptoms	  of	   the	   aforementioned	  diseases:	   	   angina,	   abnormal	  dyspnea,	   syncope,	  orthopnea/paroxysmal	   nocturnal	   dyspnea,	   ankle	   edema,	   tachycardia,	   intermittent	  claudication,	  and	  unusual	  fatigue	  with	  usual	  activities.	  	  Use	  of	  prescription	  medications	  that	  may	  influence	  performance	  and/or	  hemostatic	  parameters	  under	  investigation	  were	  cause	  for	  exclusion	  from	  the	  study.	  	  Any	  enrolled	  subjects	  who	  exhibited	  symptoms	  indicative	  of	  cardiovascular	  distress	  during	  participation	  were	  eliminated	   from	  further	   involvement	   in	  the	  study.	  
Definition	  of	  Terms	  1) Hemostasis	  –	  Pertaining	  to	  the	  movement	  or	  lack	  of	  movement	  of	  the	  blood.	  	  2) Coagulation	  –	  The	  process	  of	  the	  formation	  of	  a	  blood	  clot.	  3) Thrombosis	  –	  The	  formation	  or	  presence	  of	  a	  blood	  clot	  in	  the	  circulatory	  system.	  4) Sedentary	   –	   Less	   than	   two	   days,	   30	  minutes	   per	   day,	   of	   aerobic	   physical	   activity	  within	  the	  past	  three	  months.	  5) High-­‐intensity	   interval	  training	  (HIIT)	  –	  Characterized	  by	  short,	   intermittent	  bouts	  of	   vigorous	   physical	   activity,	   interspersed	   with	   brief	   periods	   of	   passive	   or	   low	  intensity	  active	  recovery.	  	  	  	  	  	  	  


















	  Cardiovascular	  disease	  (CVD)	  is	  the	  most	  common	  cause	  of	  mortality	  in	  the	  United	  States,	   and	   was	   responsible	   for	   one	   out	   of	   every	   three	   deaths	   in	   2010	   [30].	   	   The	   most	  common	   types	  of	  CVD,	   including	  myocardial	   infarction,	   stroke,	   and	  sudden	  cardiac	  death	  are	   caused	   by	   the	   formation	   of	   an	   occlusive	   thrombus	   [4].	   	   Such	   thrombotic	   events	   are	  related	  to	  blood	  coagulation	  and	  fibrinolytic	  activity	  [5].	  	  The	  hemostatic	  system	  is	  affected	  by	  several	  different	  mechanisms	  including	  age,	  sex,	  smoking,	  obesity,	  and	  physical	  activity	  [26,	  27,	  31-­‐33].	  	  	  Previous	   research	   indicates	   that	   regular	   exercise	   training	  has	  been	   shown	   to	  be	  a	  plausible	  contributor	  to	  the	  reduction	  of	  cardiac	  events	  because	  of	  its	  direct	  effects	  on	  the	  body’s	  vasculature	  and	  the	  shear	  stress	  that	  is	  placed	  on	  the	  endothelium	  [23].	   	  However,	  research	  regarding	  the	  hemostatic	  system	  and	  endurance	  training	  has	  produced	  equivocal	  results.	   	   Some	   studies	   show	   an	   increase	   in	   coagulation	   potential	   [12-­‐14],	   others	   show	   a	  decrease	   in	   coagulation	   potential	   [10,	   11,	   15],	   and	   some	   show	   no	   change	   in	   coagulation	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potential	  [16].	  	  While	  several	  studies	  have	  shown	  endurance	  training	  to	  be	  most	  beneficial	  to	   the	   hemostatic	   system,	   no	   research	   has	   shown	   the	   effect	   of	   high-­‐intensity	   interval	  training	   (HIIT)	   on	   the	   hemostatic	   system.	   	   Despite	   the	   recognized	   benefits	   of	   regular	  exercise	  and	  the	  known	  dose-­‐response	  relationship	  between	  activity	  and	  disease,	  there	  is	  no	   consensus	   regarding	   the	   dose	   of	   exercise	   needed	   to	   promote	   desired	   physiological	  adaptations	   [28,	   29].	   	   Thus,	   the	   purpose	   of	   this	   investigation	  was	   to	   determine	  whether	  healthy	  adults	  experience	  an	   increased	  or	  decreased	  coagulation	  potential	   following	   four	  and	  eight	  weeks	  of	  a	  HIIT	  intervention.	  	  Based	  upon	  previous	  findings	  and	  the	  theory	  that	  exercise	   training	   reduces	   blood	   coagulation,	   it	   is	   hypothesized	   that	   HIIT	   will	   reduce	  coagulation	  potential	  following	  four	  and	  eight	  weeks	  of	  HIIT.	  
Blood	  Coagulation	  
	   Although	  complex	  in	  nature,	  the	  coagulation	  cascade	  is	  an	  important	  mechanism	  for	  preventing	  excessive	  blood	   loss	   from	  an	   injured	  blood	  vessel	   [34].	   	   Following	   injury	   to	  a	  blood	  vessel,	  vasoconstriction	  is	  the	  first	  responsive	  mechanism	  to	  control	   for	  blood	  loss.	  	  However,	  because	  vasoconstriction	  alone	  is	  not	  enough	  to	  completely	  stop	  blood	  flow,	  the	  formation	  of	  a	  clot	  is	  necessary.	  	  Clot	  formation	  begins	  when	  platelets	  flowing	  through	  the	  blood	   vessel	   attach	   to	   exposed	   collagen	   and	   become	   activated.	   	   Upon	   activation,	   the	  platelets	   release	   adenosine	   diphosphate	   and	   thromboxane	   A2.	   	   Adenosine	   diphosphate	  attracts	   more	   platelets	   into	   the	   injured	   area	   and	   thromboxane	   A2	   promotes	  vasoconstriction	   and	   platelet	   aggregation.	   	   This	   mechanism	   works	   in	   positive	   feedback	  fashion	   to	   form	   the	   platelet	   plug.	   	   Following	   the	   formation	   of	   the	   platelet	   plug,	   the	  coagulation	  cascade	  takes	  over	  to	  form	  the	  rest	  of	  the	  blood	  clot.	  	  A	  major	  protein	  of	  blood	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coagulation,	  fibrin,	  is	  recruited	  to	  form	  the	  cross-­‐linked	  fibrin	  clot.	  	  The	  cross-­‐linked	  fibrin	  clot	  is	  the	  final	  piece	  of	  the	  coagulation	  cascade.	  	   The	   coagulation	   cascade	   consists	   of	   three	   pathways:	   the	   intrinsic	   pathway,	   the	  extrinsic	   pathway,	   and	   the	   common	   pathway.	   	   A	   damaged	   surface	   and	   exposed	   proteins	  found	   in	   the	   blood	   stream	   including	   high-­‐molecular-­‐weight	   kininogen,	   prekallikrein,	   and	  factor	  XII	  initiate	  the	  intrinsic	  pathway.	  On	  the	  contrary,	  the	  extrinsic	  pathway	  is	  initiated	  by	   trauma	  and	   the	  exposure	  of	   tissue	   factor	   from	  the	  subendothelium.	   	  Tissue	   factor	   is	  a	  cell	  membrane	  protein	  that	  does	  not	  travel	  in	  the	  blood	  stream.	  	  The	  intrinsic	  and	  extrinsic	  pathways	   lead	   to	   the	   formation	  of	   factor	  X,	  which	   is	  where	   the	  common	  pathway	  begins.	  	  The	  common	  pathway	  is	  initiated	  by	  factor	  X	  and	  completed	  when	  a	  cross-­‐linked	  fibrin	  clot	  is	  formed.	  	  The	  three	  pathways	  mentioned	  above	  work	  in	  conjunction	  to	  form	  a	  blood	  clot.	  	  Several	   enzymes	   work	   together	   and	   in	   positive	   feedback	   fashion	   to	   activate	   other	  substrates	  and	  stimulate	  the	  formation	  of	  other	  enzymes.	  	  	  	   The	   intrinsic	   pathway	   is	   very	   important	   for	   the	   amplification	   of	   the	   coagulation	  cascade.	  	  While	  the	  initial	  activation	  of	  factor	  X	  is	  from	  the	  extrinsic	  pathway,	  the	  intrinsic	  pathway	   amplifies	   this	   activation	   [35,	   36].	   	   The	   formation	   of	   the	   primary	   complex	   on	  collagen	   begins	   with	   three	   important	   proteins:	   high-­‐molecular-­‐weight	   kininogen,	  prekallinkrein,	   and	   factor	   XII.	   	   Prekallikrein	   is	   converted	   to	   kallikrein	   and	   factor	   XII	   is	  activated	   when	   it	   comes	   in	   contact	   with	   negatively	   charge	   surfaces.	   	   Factor	   XIIa	   causes	  factor	  XI	   to	  become	  activated.	   	  Next,	   factor	  XIa	   converts	   factor	   IX	   into	   its	   activated	   form,	  factor	   IXa.	   	   Factor	   IXa	   then	   needs	   the	   help	   of	   factor	   VIIIa,	   converted	   from	   factor	   VIII,	   to	  activate	  factor	  X	  to	  factor	  Xa.	  	  Factor	  Xa	  is	  the	  final	  product	  of	  the	  intrinsic	  pathway.	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The	  extrinsic	  pathway	  is	   less	  complex.	   	  Following	  damage	  to	  a	  blood	  vessel,	   factor	  VII	   leaves	  the	  circulation	  and	  comes	  in	  contact	  with	  a	  negatively	  charged	  surface,	  such	  as	  tissue	   factor	   or	   collagen	   from	   within	   the	   arterial	   wall.	   	   Tissue	   factor	   is	   released	   from	  damaged	  tissue	  and	  at	  the	  same	  time,	  factor	  VII	  is	  converted	  to	  its	  active	  form,	  factor	  VIIa.	  	  Factor	  VIIa	  combines	  with	  tissue	  factor	  to	  convert	  factor	  X	  to	  factor	  Xa.	  	  This	  is	  where	  the	  intrinsic	  and	  extrinsic	  pathways	  meet	  to	  form	  the	  common	  pathway.	  	  	  The	  final	  pathway	  of	  the	  coagulation	  cascade,	  the	  common	  pathway,	  contains	  three	  major	   reactions	   that	   each	   represent	   a	   rate	   limiting	   step	   of	   the	   coagulation	   cascade.	  	  Initially,	   factor	   X	   is	   activated	   via	   the	   products	   of	   the	   intrinsic	   and	   extrinsic	   pathways	  through	  their	  respective	  enzymes.	  	  Next,	  factor	  Xa	  converts	  prothrombin	  to	  thrombin	  with	  the	  help	  of	  factor	  Va,	  which	  was	  converted	  from	  factor	  V.	  	  Finally,	  thrombin	  then	  converts	  fibrinogen	  to	  fibrin.	   	  Thrombin	  plays	  an	  important	  role	  in	  positive	  feedback	  for	  the	  entire	  coagulation	  process	  as	  it	  accelerates	  the	  production	  of	  factor	  XIa,	  factor	  VIIIa,	  and	  factor	  Va.	  	  This	  amplifies	  the	  cascade	  to	  produce	  enough	  fibrin,	  the	  final	  protein	  in	  the	  formation	  of	  a	  blood	  clot,	  in	  a	  short	  amount	  of	  time	  [34].	  Coagulation	   potential	   is	   generally	   measured	   in	   four	   common	   ways:	   measures	   of	  activated	  partial	  thromboplastin	  time	  (APTT)	  and	  prothrombin	  time	  (PT),	  and	  measures	  of	  protein	  activity	  of	  fibrinogen	  and	  factor	  VIII	  [26,	  27].	  	  	  APPT	  measures	  the	  time	  it	  takes	  to	  get	   through	   the	   intrinsic	   pathway	   and	   PT	  measures	   the	   time	   it	   takes	   to	   get	   through	   the	  extrinsic	   pathway.	   	   Furthermore,	   measures	   of	   fibrinogen	   and	   factor	   VIII	   are	   based	   on	  concentration	   levels	   in	   the	  blood.	   	  The	  more	  concentrated	   these	  proteins,	   the	  greater	   the	  coagulation	  potential.	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The	   coagulation	   cascade,	   formed	   through	   the	   intrinsic,	   extrinsic,	   and	   common	  pathways,	  can	  be	  seen	  below	  in	  Figure	  A.	  	  Note	  that	  the	  three	  pathways	  of	  the	  coagulation	  cascade	  are	  not	  equally	  exclusive	  of	  one	  another.	  	  Enzymes	  from	  one	  pathway	  may	  activate	  substrates	   in	   another	   pathway	   and	   vice	   versa.	   	  Many	   of	   these	   enzymes	  work	   in	   positive	  feedback	  fashion,	  which	  helps	  to	  amplify	  the	  cascade	  and	  ensure	  that	  adequate	  amounts	  of	  fibrin	  are	  formed	  throughout.	  	  Overall,	  a	  hemostatic	  plug	  that	  occludes	  the	  flow	  of	  blood	  in	  an	  injured	  vessel	  is	  formed	  through	  this	  cascade.	  
	  
Figure	  A	  –	  The	  coagulation	  cascade	  and	  it	  respective	  pathways	  that	  lead	  to	  the	  formation	  of	  a	  cross-­‐linked	  fibrin	  clot.	  	  Several	  proteins,	  also	  known	  as	  factors,	  work	  in	  conjunction	  to	  form	   and	   activate	   substrates	   to	   eventually	   halt	   the	   flow	   of	   blood	   through	   the	   wall	   of	   a	  damage	   blood	   vessel.	   	   A	   solid	   arrow	   (à)	   indicates	   direct	   conversion	   of	   one	   factor	   to	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another	  and	  a	  dashed	  arrow	  (-­‐-­‐>)	   indicates	  thrombin	  acting	  on	  other	  proteins	   in	  positive	  feedback	  fashion	  [37].	  
Blood	  Coagulation	  and	  Health	  The	   ability	   of	   one’s	   blood	   to	   clot,	   or	   the	   coagulation	   potential,	   has	   been	   directly	  related	   to	   various	   cardiovascular	   risk	   factors	   and	   to	   the	   onset	   of	   several	   adverse	  cardiovascular	   events	   [5].	   	   An	   increase	   in	   the	   likelihood	   of	   thrombus	   formation,	   or	  thrombosis,	  can	  increase	  one’s	  risk	  for	  CVD	  [2]	  or	  the	  incidence	  of	  several	  cardiovascular	  events	  including	  myocardial	  infarction,	  stroke,	  angina,	  and	  sudden	  cardiac	  death	  [4,	  38-­‐40].	  	  While	   factor	   VII	   and	   factor	   VIII	   have	   been	   shown	   to	   be	   positively	   and	   independently	  associated	  with	   the	   incidence	   of	   thrombus	   formation	   [41].	   	   Although	   fibrinogen	   has	   not	  been	   directly	   associated	   with	   thrombus	   formation,	   it	   is	   commonly	   identified	   as	   an	  independent	   risk	   factor	   for	   CVD	   [42].	   	   While	   the	   coagulation	   cascade	   contains	   many	  proteins,	  these	  specific	  plasma	  proteins	  have	  been	  shown	  to	  consistently	  change	  with	  the	  onset	  of	  CVD	  [39,	  41,	  42].	  	  An	  increased	  plasma	  concentration	  of	  these	  coagulation	  cascade	  enzymes	   (e.g.,	   factor	   VIII	   and	   fibrinogen)	   leads	   to	   an	   increased	   potential	   for	   blood	  coagulation.	  While	   an	   increased	   coagulation	   potential	   is	   associated	   with	   an	   increased	   risk	   for	  disease,	   a	   reduced	   coagulation	   potential	   has	   been	   related	   to	   an	   overall	   improvement	   in	  health	   [23].	   	  Markers	   of	   blood	   coagulation	   have	   been	   studied	   extensively	   and	   related	   to	  outcomes	  of	  coronary	  disease	  in	  several	  cohorts	  and	  populations	  [4].	  	  Higher	  plasma	  levels	  of	  factor	  VII	  activity	  have	  been	  related	  to	  cardiac	  death	  [43],	  while	  higher	  plasma	  levels	  of	  fibrinogen	   have	   been	   related	   to	   myocardial	   infarction	   and	   cardiac	   death	   [43-­‐45].	  	  Therefore,	  lower	  plasma	  levels	  of	  these	  proteins	  are	  associated	  with	  a	  reduced	  coagulation	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potential.	   	   However,	   blood	   coagulation	   parameters	   are	   affected	   by	   several	   risk	   factors	  including:	  age,	  sex,	  smoking,	  alcohol,	  and	  obesity	  [31,	  32,	  46-­‐48].	  	  	  	   Several	  proteins	   that	  are	   important	  markers	  of	  blood	  coagulation	   (e.g.,	   fibrinogen,	  factor	   VII,	   factor	   VIII)	   have	   been	   related	   to	   the	   incidence	   of	   CVD	   and	   other	   adverse	  outcomes	  through	  aging.	  	  Factor	  VII,	  factor	  VIII,	  and	  fibrinogen	  are	  associated	  with	  aging,	  as	  increased	  plasma	  levels	  have	  been	  observed	  in	  the	  elderly	  [31].	  	  Likewise,	  Sugawara	  et	  al.	  determined	  that	  plasma	  levels	  of	  most	  coagulation	  factors	  are	  significantly	  increased	  with	  aging	  in	  sedentary	  men,	  although	  this	  tendency	  seems	  to	  disappear	  in	  regularly	  active	  men.	  	  They	   specifically	   stated	   that	   the	  most	   prominent	   increases	   in	   coagulation	   proteins	  were	  seen	   in	   fibrinogen,	   factor	   IX,	  and	   factor	  XIII	   [5].	   	  Following	  regular	  physical	   conditioning,	  Van	  Den	  Burg	  and	  colleagues	  determined	  that	  factor	  VIII	   levels	  were	  most	  pronounced	  in	  young	   individuals	   while	   thrombin	   formation	   was	   most	   pronounced	   in	   older	   individuals	  [14].	   	   A	   comparison	   study	   between	   the	   young	   and	   the	   elderly	   showed	   that	   the	   elderly	  possess	   an	   increased	   plasma	   concentration	   of	   coagulation	   proteins,	  which	   led	   to	   shorter	  clotting	  times	  and	  an	  increased	  coagulation	  potential.	  	  Specifically,	  the	  elderly	  experienced	  an	  increase	  in	  fibrinogen	  [49].	  	  Many	  of	  the	  proteins	  that	  have	  been	  shown	  to	  be	  increased	  dependent	  upon	  age	  are	  risk	   factors	   for	  thrombotic	  disease	  [31]	  and	  a	  reason	  for	   further	  investigations.	  	  It	  is	  also	  important	  to	  note	  that	  genetic	  and	  environmental	  factors	  such	  as	  diet,	   smoking,	   exercise,	   and	   hormonal	   status	   modulate	   hemostatic	   parameters	   through	  aging	  [50].	  	   Furthermore,	   an	   increased	   coagulation	   potential	   has	   been	   related	   to	   gender,	  specifically	   with	   regards	   to	   women,	   pregnancy,	   and	   oral	   contraceptives	   [46,	   51,	   52].	   	   A	  study	  that	  used	  thromboelastography,	  a	  point-­‐of-­‐care	  monitor	  of	  whole	  blood	  coagulation,	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found	  that	  women	  have	  higher	  clotting	  activity	  than	  men.	  	  In	  comparing	  men,	  non-­‐pregnant	  women,	   and	   pregnant	   women,	   it	   was	   determined	   that	   women	   have	   an	   increased	  coagulation	   potential	   compared	   to	   men,	   and	   pregnant	   women	   experience	   the	   most	  increased	  coagulation	  potential	  [46].	  	  Specifically,	  in	  pregnancy,	  a	  hypercoagulable	  state	  is	  developed	  because	  of	  an	  increase	  in	  several	  protein	  concentrations	  (i.e.,	  factor	  II,	  factor	  VII,	  factor	   VIII,	   factor	   X,	   and	   factor	   XI)	   [51].	   	   Another	   article	   shows	   that	   women	   experience	  increased	  concentrations	  of	  fibrinogen	  and	  factor	  VIII,	  which	  would	  explain	  sex	  differences	  in	  blood	   coagulation	  potential	   [53].	   	  A	   few	  studies	   extended	   their	   investigations	   to	   show	  that	  like	  pregnancy,	  oral	  contraceptives	  have	  a	  similar	  effect	  on	  overall	  blood	  coagulation	  [52,	  54].	  	  Rosendaal	  and	  colleagues	  took	  an	  in-­‐depth	  look	  at	  thrombosis	  and	  concluded	  that	  venous	   thrombosis	   in	   young	   women	   can	   commonly	   be	   attributed	   to	   use	   of	   oral	  contraceptives	   [52].	   	   However,	  Winkler	   argued	   that	   not	   all	   oral	   contraceptives	   have	   the	  same	   outcome	   on	   overall	   markers	   of	   blood	   coagulation	   [54].	   	   While	   the	   use	   of	   oral	  contraceptives	   is	   associated	   with	   altered	   plasma	   levels	   of	   several	   proteins	   of	   the	  coagulation	  system,	  not	  all	  populations	  respond	  the	  same	  and	  further	  research	  needs	  to	  be	  executed	  [54].	  	   Although	  controllable,	  another	  major	  risk	  factor	  for	  increased	  coagulation	  potential	  is	  cigarette	  smoking.	   	  However,	  regular	  cigarette	  smoking	  has	  produced	  equivocal	  results	  with	  regards	  to	  blood	  coagulation.	  	  Some	  studies	  have	  correlated	  regular	  cigarette	  smoking	  with	  higher	  coagulation	  protein	  levels	  [55,	  56]	  while	  others	  have	  shown	  no	  negative	  effects	  of	  regular	  cigarette	  smoking	  [47,	  57].	  	  It	  is	  postulated	  that	  the	  nicotine	  in	  cigarettes	  is	  what	  causes	   an	   increased	   coagulation	   potential	   because	   of	   the	   vasoconstrictive	   action	   of	  nicotine.	  	  However,	  the	  same	  authors	  argued	  that	  the	  act	  of	  deep	  breathing	  might	  induce	  a	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similar	  degree	  of	  vasoconstriction	  [58].	   	  Although	  vasoconstriction	   is	  an	   important	   initial	  stage	   of	   blood	   clotting,	   a	   change	   in	   protein	   levels	   will	   be	   the	   ultimate	   factor	   that	   alters	  blood	  coagulability.	  	  Mustard	  and	  Murphy	  conducted	  a	  study	  that	  showed	  no	  changes	  in	  the	  importance	   of	   blood	   coagulation	   in	   response	   to	   heavy	   smoking	   [47].	   	   Likewise,	   another	  study	   found	  that	   following	  a	  meal,	   the	  protein	  rise	   in	  smokers	  was	   less	   than	   that	  of	  non-­‐smokers,	   leading	   to	   a	   negligible	   difference	   in	   blood	   coagulation	   [57].	   	   On	   the	   contrary,	  several	   studies	   found	   regular	   smoking	   to	   have	   a	   significant	   increase	   on	   coagulation	  potential.	   	  Billimoria	  et	  al.	  measured	  serum	  levels	  of	  many	  coagulation	  proteins	  as	  well	  as	  clotting	  times,	  and	  showed	  a	  shortened	  PT	  in	  smokers	  compared	  to	  non-­‐smokers	  [56].	   	  A	  more	  recent	  study	  suggested	  that	  elevated	  factor	  XIII	  levels	  due	  to	  smoking	  are	  associated	  with	  the	  pathogenesis	  of	  vascular	  disease.	   	  They	  also	  concluded	  that	   factor	  XIII	  activity	   is	  significantly	  related	  to	  fibrinogen	  levels	  [55].	  	  	  Alcohol	  consumption	  has	  also	  been	  shown	  to	  affect	  coagulation	  potential.	   	  Light	  to	  moderate	   alcohol	   consumption	   (i.e.,	   up	   to	   one	   drink	   per	   day	   for	   women	   and	   up	   to	   two	  drinks	   per	   day	   for	  men)	   has	   been	   associated	  with	   a	   reduced	   coagulation	   potential	   [48].	  	  While	  the	  usage	  of	  recreational	  drugs	  is	  never	  advised,	  the	  hemostatic	  system	  may	  respond	  differently	   dependent	   upon	   the	   type	   of	   alcoholic	   beverage,	   sex,	   time	   of	   day,	   and	   during	  exercise	  [48,	  55].	  	   Obesity	   is	   a	  major	   risk	   factor	   for	   cardiovascular	   disease	   in	   both	  men	   and	  women	  [59,	   60].	   	   It	   is	  well	   known	   that	   obesity	   is	   correlated	  with	   an	   increase	   in	   several	   plasma	  proteins	   including	   von	  Willebrand	   factor,	   fibrinogen,	   factor	   VII,	   and	   factor	   VIII	   [32,	   61].	  	  The	  underlying	  mechanism	  for	  the	  increase	  in	  coagulation	  potential	  and	  obesity	  lies	  within	  the	   adipocyte	   itself.	   	   The	   adipocyte	   is	   able	   to	   produce	  plasminogen	   activator	   inhibitor-­‐1,	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which	  explains	  the	  high	  plasma	  levels	  of	  proteins	  [32].	   	  The	  relationship	  between	  obesity	  and	  an	  increase	  in	  coagulation	  potential	  is	  well	  understood	  and	  known	  to	  promote	  a	  pro-­‐thrombotic	   state,	   which	   increases	   one’s	   likelihood	   of	   CVD	   [32].	   	   Other	   factors,	   such	   as	  dietary	  lifestyle	  [61]	  and	  insulin	  sensitivity	  [32],	  have	  been	  shown	  to	  be	  associated	  with	  the	  prothrombotic	  state	  that	  obesity	  brings	  but	  hemostatic	  variables	  are	  the	  most	  well	  known.	  A	   prothrombotic	   state	   is	   directly	   related	   to	   an	   increased	   risk	   for	   CVD	   and	   can	   be	  caused	  by	  several	  mechanisms,	   including:	  age,	   sex,	   smoking,	  alcohol,	   and	  obesity	   [31,	  32,	  46-­‐48].	  	  However,	  even	  if	  these	  mechanisms	  are	  not	  present,	  a	  prothrombotic	  state	  is	  still	  independently	   associated	  with	   adverse	   cardiovascular	   events	   [23].	   	   Research	   has	   shown	  that	  an	  increased	  coagulation	  potential	  may	  be	  present	  in	  healthy	  individuals	  who	  do	  not	  otherwise	   have	   risk	   factors	   for	   cardiovascular	   disease	   [42].	   	   	   A	   reduced	   coagulation	  potential	  has	  been	  related	  to	  an	  overall	  improvement	  in	  health	  [23],	  but	  several	  variables	  of	   the	  hemostatic	  system	  can	  be	  easily	  affected	  by	  slight	  changes	   to	   the	  body.	   	  Discussed	  below,	   blood	   coagulation	  may	   or	  may	  not	   be	   altered	   following	   exercise,	  whether	   it	   is	   an	  acute	  bout	  or	  a	  longer-­‐term	  exercise	  training	  program.	  
Exercise	  Training	  and	  Blood	  Coagulation	  Regular	   exercise	   training	   is	   inversely	   related	   to	   the	   incidence	   and	   risk	   of	   several	  adverse	  outcomes	  associated	  with	  CVD	  and	  other	  chronic	  diseases	  [62].	  	  Despite	  the	  large	  body	  of	  evidence	  supporting	  the	  benefits	  of	  regular	  physical	  activity	  and	  the	  known	  dose-­‐response	   relationship	   between	   activity	   and	   disease,	   there	   is	   no	   consensus	   regarding	   the	  required	  dose	  of	  exercise	  needed	  to	  promote	  desired	  physiological	  outcomes	  [28].	   	  While	  regular	  physical	  activity	  promotes	  a	  cardioprotective	  state,	   the	  outcomes	  with	  regards	   to	  the	  hemostatic	  system	  remain	  controversial	  or	  unknown.	  	  The	  three	  main	  types	  of	  exercise	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training	  that	  have	  been	  related	  to	  blood	  coagulation	  include:	  endurance	  training,	  resistance	  training,	  and	  HIIT.	  	  	  Changes	   in	   APTT,	   PT,	   and	   concentrations	   of	   fibrinogen	   and	   factor	   VIII	   have	   been	  related	  to	  a	  significant	  change	  in	  overall	  coagulation	  potential	  [26].	   	  Several	  studies	  use	  a	  cross	  sectional	  approach	  to	  compare	  blood	  coagulation	  potential	  related	  to	  different	  fitness	  or	   physical	   activity	   levels.	   	   Ferguson	   et	   al.	   compared	   three	   groups	   of	   individuals:	  marathoners,	   joggers,	   and	   sedentary	   individuals,	   and	   determined	   that	   there	   were	   no	  differences	  in	  APTT	  and	  PT	  between	  groups	  at	  rest	  and	  post	  exercise	  [12].	  	  Subjects	  in	  this	  study	  all	  possessed	  significantly	  different	  VO2	  max	  values	  suggesting	  that	  coagulation	  and	  VO2	   are	   not	   correlated.	   	   Another	   study	   screened	   for	   physical	   activity	   level	   and	   found	  no	  significant	  differences	   in	  APTT	  between	  groups	  at	  rest	  [63].	   	  Likewise,	  El-­‐Sayed	  observed	  significant	  differences	  in	  VO2	  max	  in	  a	  mixed	  sample	  and	  found	  no	  changes	  in	  coagulation	  activity	   [64].	   	   However,	   several	   cross	   sectional	   studies	   consistently	   observed	   an	   inverse	  relationship	  between	  regular	  physical	  activity	  and	  fibrinogen	  [15,	  63,	  65-­‐68]	  and	  factor	  VIII	  activity	   levels	   [63,	   69].	   Furthermore,	   Rankinen	   et	   al.	   observed	   an	   inverse	   correlation	  between	   fibrinogen	   levels	   and	   VO2	  max	   [70].	   	   The	   inability	   of	   these	   studies	   to	   establish	  cause	   and	   effect	   or	   eliminate	   other	   factors	   (e.g.,	   genetic	   and	   environmental)	   is	   why	  longitudinal	  studies	  are	  preferred	  and	  also	  why	  more	  research	   is	  needed	  with	  regards	   to	  this	  topic	  and	  different	  modes	  of	  exercise	  training.	  
Endurance	  Training	  	   While	  endurance	  training	  is	  the	  most	  commonly	  researched	  mode	  of	  exercise,	  it	  has	  produced	   the	  most	   equivocal	   results	   with	   regards	   to	   blood	   coagulation	   [26,	   27].	   	   APTT,	  which	  measures	  the	  time	  it	  takes	  to	  get	  through	  the	  intrinsic	  pathway,	  has	  been	  shown	  to	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be	   prolonged	   with	   exercise	   training	   [10,	   71],	   but	   some	   studies	   suggest	   a	   significant	  shortening	  in	  clotting	  times	  [14,	  63].	  	  Suzuki	  and	  colleagues	  demonstrated	  that	  four	  weeks	  of	   physical	   training	   suppressed	  blood	   coagulation	   via	   a	  prolongation	   in	  APTT	   [71].	   	   This	  study	  observed	  56	  post-­‐myocardial	  infarction	  patients	  (men	  and	  women)	  before	  and	  after	  one	   month	   of	   physical	   training.	   	   The	   moderate	   intensity,	   high	   volume	   training	   protocol	  consisted	  of	   cycling	  and	  walking	   for	   two	   times	  a	  day,	   six	  days	  a	  week.	   	  Likewise,	  Hilberg	  and	  associates	  showed	  that	  twelve	  weeks	  of	  endurance	  training	  had	  a	  significant	  influence	  on	   the	   prolongation	   of	   APTT	   at	   rest	   and	   following	   an	   acute	   exercise	   bout	   compared	   to	  before	  the	  training	  program	  [10].	  The	  subjects	   in	  this	  study	  were	  healthy	  untrained	  men,	  aged	   40-­‐60	   years	   old.	   	   These	   individuals	   walked,	   ran,	   or	   biked	   at	   80-­‐100%	   of	   their	  individual	  anaerobic	  threshold	  for	  60	  minutes	  three	  to	  four	  times	  a	  week.	  	  	  On	   the	   contrary,	   a	   study	   using	  moderately	   active	   but	   untrained	   subjects	   found	   a	  significant	   shortening	   in	   APTT	   following	   a	   maximal	   exercise	   test	   both	   before	   and	   after	  twelve	  weeks	   of	   aerobic	   cycling	   [64].	   	   Subjects	   exercised	   for	   30	  minutes,	   three	   days	   per	  week	  at	  an	  intensity	  of	  70-­‐80%	  of	  maximum	  heart	  rate.	  	  Another	  longitudinal	  study,	  with	  a	  similar	   training	   protocol,	   demonstrated	   that	   twelve	   weeks	   of	   aerobic	   conditioning	   also	  resulted	   in	  a	   shortening	  of	  APTT	   in	   sedentary	  men	   [14].	   	  Although	   the	  measures	   for	   this	  study	  were	   taken	  at	   rest,	   it	  produced	  similar	   results	   to	   the	   study	  mentioned	  above.	   	  Van	  den	  Burg	  et	  al.	  observed	  sedentary	  men	  of	  all	  ages	  who	  exercised	  twice	  a	  week	  for	  one	  hour	  at	  60-­‐70%	  of	  VO2	  max.	  	   Another	  measure	  of	  clotting	  time,	  PT,	  or	  the	  time	  it	  takes	  to	  get	  through	  the	  extrinsic	  pathway,	   has	   produced	   inconsistent	   results	   as	  well	   [10,	   11,	   71].	   	   Suzuki’s	   study	   of	   post-­‐myocardial	   infarction	  patients	   also	  demonstrated	   that	   exercise	   training	  did	  not	   affect	   PT	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[71].	   	   Similarly,	   the	   study	   by	   Hilberg	   et	   al.,	   described	   above,	   showed	   that	   PT	   was	   not	  affected	  following	  12	  weeks	  of	  aerobic	  exercise	  training	  pre	  and	  post	  an	  acute	  exercise	  bout	  [10].	  	  Lockard	  et	  al.	  conducted	  a	  study	  that	  suggests	  that	  moderate	  endurance	  training	  has	  a	  beneficial	  effect	  of	  reducing	  coagulation	  potential	   in	  the	  common	  pathway.	   	   	   	  Sedentary	  men	  and	  women	  underwent	  aerobic	  exercise	  training	  three	  days	  a	  week	  for	  six	  months	  at	  exercise	   duration	   and	   intensity	   of	   40	   min	   at	   70%	   heart	   rate	   reserve.	   	   Although	   not	  measuring	  the	  extrinsic	  pathway	  directly,	  they	  concluded	  that	  the	  training	  induced	  changes	  of	   clotting	   potential	   are	   independent	   upon	   lipid	   profile,	   body	   composition,	   and	   aerobic	  capacity	  [11].	  	   Plasma	   fibrinogen	   levels	   are	   commonly	   measured	   when	   it	   comes	   to	   coagulation	  potential	   [26],	   but	   yield	   conflicting	   results.	   	   Ernst	   et	   al.	   conducted	   a	   study	   on	   sedentary	  males	   and	   showed	   that	   nine	   weeks	   of	   endurance	   training	   reduced	   fibrinogen	   levels	  compared	   to	   the	   control	   group	   [72].	   	   Another	   study,	   examining	   post-­‐bypass	   patients,	  showed	   that	   fibrinogen	   levels	   decreased	   significantly	  with	   aerobic	   training	   compared	   to	  power	   training	   or	   no	   formal	   exercise	   training	   following	   three	   and	   six	   months	   [73].	  	  Likewise,	   Stratton	   and	   associates	   observed	   a	   decrease	   in	   fibrinogen	   levels	   following	   six	  months	  of	  intense	  endurance	  training	  [74].	  	  	  A	  study	  in	  1997	  observed	  the	  opposite	  changes	  in	  fibrinogen.	  	  Schuit	  et	  al.	  found	  an	  increase	   in	   plasma	   fibrinogen	   following	   exercise	   training	   in	   the	   elderly	   [75].	   	   This	   study	  consisted	  of	  829	  independently	  living	  elderly	  men	  and	  women,	  aged	  60-­‐80,	  exercising	  on	  a	  bicycle	   at	   50-­‐70%	   of	   maximal	   heart	   rate.	   	   The	   increase	   in	   fibrinogen	   levels	   may	   be	  attributed	   to	   the	  elderly	  cohort	   in	   this	  study	  and	  the	  delayed	  mechanisms	   in	  response	   to	  extensive	   exercise	   training.	   	   A	   few	   other	   studies	   [76,	   77]	   also	   found	   an	   increase	   in	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fibrinogen	   levels	   in	   trained	   individuals	   several	   days	   after	   an	   exercise	   stimulus.	  	  Montgomery	  et	  al.	  observed	  165	  male	  army	  recruits	  before	  and	  after	  their	  10-­‐week	  basic	  training	  camp	  [76].	  	  Although	  the	  protocol	  was	  only	  described	  as	  vigorous	  physical	  fitness,	  the	  unique	  program	  may	  explain	  the	  increase	  in	  fibrinogen.	  	  	  Ponjee	  et	  al.	  also	  observed	  an	  increase	   in	   fibrinogen	  with	  a	   training	  program	  that	   involved	  sedentary	  men	  and	  women.	  	  These	   subjects	   trained	   four	   times	   a	   week	   at	   increasing	   intensities	   for	   nine	   months,	   to	  prepare	  for	  a	  half-­‐marathon	  race	  [77].	  While	  several	  studies	   indicate	  an	   increase	  or	  decrease	   in	  plasma	  fibrinogen	   levels,	  some	  studies	  suggest	  that	  fibrinogen	  levels	  do	  not	  change	  in	  response	  to	  regular	  endurance	  training.	   	   Different	   populations	   of	   males	   who	   have	   undergone	   endurance	   training	  demonstrated	  no	  change	  in	  plasma	  fibrinogen	  [78,	  79].	  	  Rauramaa	  and	  colleagues	  observed	  140	  middle	   aged	  men	   over	   a	   three	   year	   long,	   low	   intensity	   exercise	   intervention,	  which	  may	  explain	  their	  findings	  [78].	   	  Similarly,	  Tisi	  observed	  men	  and	  women	  over	  a	  yearlong	  period	  of	  low	  intensity	  exercise,	  involving	  walking	  and	  leg	  exercises	  [79].	  	   Studies	   regarding	   factor	   VIII	   activity	   and	   factor	   VIII	   antigen	   levels	   also	   have	  produced	   inconsistent	   results	   following	   endurance	   training.	   	   Investigations	   pertaining	   to	  sedentary	  individuals	  show	  no	  change	  in	  factor	  VIII	   following	  endurance	  training	  [14,	  80,	  81].	  	  However,	  a	  previously	  mentioned	  study	  conducted	  by	  Suzuki	  and	  colleagues	  showed	  that	   four	   weeks	   of	   endurance	   training	   lowered	   resting	   levels	   of	   factor	   VIII	   activity	   and	  factor	  VIII	  antigen	  [71].	  	  These	  results	  may	  be	  explained	  by	  the	  nature	  of	  their	  population	  who	  were	  all	  post-­‐myocardial	   infarction.	   	  Thus,	   longitudinal	   investigations	  are	  conclusive	  with	  respect	  to	  the	  influence	  of	  exercise	  training	  on	  blood	  concentrations	  of	  factor	  VIII.	  
Resistance	  Training	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Few	   studies	   have	   been	   published	   with	   regards	   to	   resistance	   training	   and	   blood	  clotting	   and,	   to	  my	  knowledge,	   there	   are	  no	  published	   longitudinal	   studies	   assessing	   the	  effect	  of	  strength	  training	  on	  coagulation	  potential.	   	  Cross-­‐sectional	  analyses	  of	  resistance	  training	  on	  blood	  clotting	  parameters	  have	  yielded	   inconsistent	   results.	   	  Nascimento	  and	  colleagues	   published	   an	   informative	   review	   on	   the	   interactions	   between	   hemostasis	   and	  resistance	   training	   in	   2012	   [82].	   	  While	  most	   of	   the	   studies	   presented	  were	   acute	   based	  resistance	   training	   studies,	   a	   few	   of	   them	   compared	   resistance	   trained	   to	   untrained	  individuals	  at	  rest.	  	  A	  study	  conducted	  in	  2005	  showed	  no	  significant	  differences	  between	  resistance	   trained	   and	   untrained	   individuals	   in	   any	   parameters	   measured,	   including	  fibrinogen	   levels	   [83].	   	   The	   same	   group	   looked	   at	   platelet	   activation	   and	   function	   the	  following	   year	   in	   resistance	   trained	   and	   untrained	   individuals	   and	   found	   no	   significant	  differences	   between	   the	   two	   groups	   [84].	   	   Likewise,	   El-­‐Sayed	   observed	   no	   significant	  differences	  in	  factor	  VIII	  activity	  over	  three	  resistance	  training	  programs	  at	  rest	  [85].	   	  El-­‐Sayed’s	  study	  consisted	  of	  nine	  common	  exercises	  straining	  major	  muscle	  groups	   in	  both	  the	  upper	  and	  lower	  body.	  A	  more	  recent	  study	  suggests	  that	  resistance	  trained	  individuals	  exhibit	   a	   lower	   capacity	   to	   from	  a	   clot	   via	  APTT	   [13].	   	   This	   group	   also	  demonstrated	  no	  changes	  in	  fibrinogen	  and	  several	  other	  hemostatic	  parameters	  between	  resistance	  trained	  and	  untrained	  individuals.	  	  Although	  fibrinogen	  levels	  were	  unchanged,	  this	  new	  insight,	  in	  contrary	  to	  findings	  in	  previous	  studies,	  suggests	  that	  habitual	  resistance	  training	  may	  be	  a	  promising	  mode	  of	  exercise	  to	  enhance	  health	  outcomes	  and	  reduce	  the	  risk	  of	  CVD	  [13].	  
Acute,	  High	  Intensity	  Exercise	  	   The	   literature	   is	   consistent	   regarding	   the	   effects	   of	   an	   acute	   bout	   of	   exercise	   on	  blood	   clotting	   potential.	   	   A	   single	   Wingate	   anaerobic	   exercise	   test	   led	   to	   a	   significant	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increase	  in	  coagulation	  parameters,	  including	  APTT	  and	  factor	  VIII	  [86].	  	  While	  this	  induces	  an	   increased	   coagulation	  potential,	   no	   investigations	  have	  been	  done	  with	   regard	   to	   this	  type	   of	   exercise	   as	   a	   training	   program.	   	   As	   shown	   in	   this	   study,	   blood	   coagulation	  parameters	  respond	  to	  acute	  bouts	  of	  this	  type	  of	  training	  and,	  because	  of	  the	  theory	  that	  exercise	   training	   reduces	   coagulation	   potential	   HIIT	  may	   be	   a	   promising	   substitute	   and	  beneficial	  mode	  of	  exercise	  training.	  
HIIT	   It	  has	  been	  shown	  that	  regular	  exercise	  training	  is	  beneficial	  to	  overall	  health	  [3,	  62,	  87].	   	   The	   American	   College	   of	   Sports	   Medicine	   (ACSM)	   recommends	   exercising	   at	   a	  moderate	  intensity	  for	  at	  least	  150	  minutes	  per	  week	  [88].	  	  This	  can	  be	  met	  through	  30-­‐60	  minutes	  of	  moderate-­‐intensity	  exercise	   five	  days	  per	  week	  or	  20-­‐60	  minutes	  of	  vigorous-­‐intensity	  exercise	   three	  days	  per	  week.	   	  Although	  many	   individuals	   struggle	   to	  meet	   this	  recommendation	   because	   of	   a	   lack	   of	   time	   [89,	   90],	   they	  may	   still	   receive	   some	  benefits	  from	  normal	  daily	  activities	  [88].	  	  It	  has	  been	  shown	  that	  lack	  of	  time	  is	  a	  recurring	  theme	  with	  regards	  to	  exercise	  referrals	  and	  compliance	  [91].	  	  A	  few	  investigations	  analyzed	  HIIT,	  and	   showed	   a	   reduced	   time	   component	   in	   comparison	   to	   endurance	   training	   [92,	   93].	  	  Meanwhile,	  it	  has	  been	  reported	  that	  participants	  perceive	  HIIT	  to	  be	  more	  enjoyable	  than	  continuous,	  moderate	  intensity	  exercise	  [94].	  Furthermore,	  because	  HIIT	  is	  a	  newer	  mode	  of	  exercise	  training,	  ACSM’s	  standard	  exercise	  recommendations	  do	  not	  incorporate	  it	  and	  there	   is	   a	   significant	   gap	   in	   the	   literature	   with	   regards	   to	   HIIT	   and	   the	   health	   benefits	  associated	  with	  this	  type	  of	  exercise	  training.	  HIIT	   is	   characterized	   by	   short,	   intermittent	   bouts	   of	   vigorous	   physical	   activity,	  interspersed	   with	   brief	   periods	   of	   passive	   or	   low-­‐intensity	   active	   recovery.	   	   The	   most	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common	  HIIT	  protocols	  use	  5-­‐30	  seconds	  of	  high	  intensity	  cycling	  or	  sprinting,	  followed	  by	  a	  brief	  recovery,	  repeated	  3-­‐6	  times	  each	  session.	  	  Recent	  studies	  with	  regard	  to	  HIIT	  have	  produced	  consistent	  results	  that	  indicate	  this	  relatively	  novel	  mode	  of	  exercise	  training	  is	  beneficial	  to	  the	  cardiovascular	  system	  [19,	  21,	  92,	  95-­‐98],	  the	  respiratory	  system	  [22,	  99,	  100],	   and	   overall	   health	   [93,	   101-­‐103]	   in	   both	   healthy	   and	   diseased	   populations	   [17-­‐21,	  104].	   	   A	   few	   studies	   have	   even	   suggested	   that	  HIIT	  may	   be	   an	   effective	   replacement	   for	  endurance	   training	   [92,	   93,	   98].	   	   While	   blood	   coagulation	   has	   not	   yet	   been	   specifically	  related	  to	  HIIT,	  this	  type	  of	  training	  has	  been	  shown	  to	  induce	  beneficial	  improvements	  in	  endothelial	   function,	  resting	  blood	  pressure,	  and	  left	  ventricular	  morphology	  [17,	  20,	  22],	  each	  of	  which	  are	  related	  to	  the	  hemostatic	  system	  [23-­‐25].	  	  	  Endothelial	   dysfunction,	   which	   is	   used	   as	   an	   independent	   prognostic	   marker	   for	  adverse	   cardiovascular	   events	   [105],	   may	   be	   improved	   following	   HIIT.	   	   Wisloff	   and	  colleagues	   conducted	   a	   study	   to	   observe	   the	   enzymatic	   responses	   of	   the	   endothelium	   in	  response	  to	  HIIT	  [20].	  	  This	  study	  examined	  the	  elderly	  population	  (aged	  75	  ±	  11.1	  years)	  and	   focused	   specifically	   on	   cardiac	   patients.	   	   They	   showed	   that	   three	   weeks	   of	   HIIT	  improved	   nitric	   oxide	   meditated	   endothelial	   function,	   and	   concluded	   that	   this	  improvement	   is	   dependent	   on	   the	   intensity	   of	   the	   exercise	   [20].	   	   The	   exercise	   training	  included	   four	  4-­‐minute	   intervals	  with	  an	  exercise	   intensity	   that	   induced	  heavy	  breathing	  for	  the	  subjects.	  	  Likewise,	  scientists	  at	  McMaster	  University	  observed	  that	  6	  weeks	  of	  HIIT	  improves	   endothelial	   function	   [98].	   	   This	   study	   observed	   significant	   changes	   in	   young,	  healthy	  men	   and	  women,	   and	   compared	   HIIT	   to	   endurance	   training	   at	   a	  matched	  work	  level.	   	   The	   HIIT	   protocol	   used	   in	   this	   study	   involved	   repeated	   Wingate	   tests	   with	   4.5	  minutes	   of	   recovery	   between	   each	   bout.	   	   A	   few	   other	   studies	   observed	   no	   significant	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improvements	   in	   endothelial	   function	   with	   severe	   physical	   training	   [106,	   107].	   	   The	  discrepant	   findings	   of	   these	   studies	   may	   be	   due	   to	   the	   different	   intensities	   of	   exercise.	  	  Bergholm	  et	   al.	   and	  Goto	  et	   al.	   observed	   light,	  moderate,	   and	  high	   intensity	   exercise	   and	  observed	  no	  endothelial	  improvements	  following	  moderate	  intensity	  exercise	  but	  observed	  improvements	  following	  high	  intensity	  exercise	  [106,	  107].	   	  The	  goal	  of	  these	  studies	  was	  to	   elucidate	  where	   the	   endothelial	   function	   training	   adaptation	   occurred	  with	   respect	   to	  different	  exercise	  intensities.	  Systolic	   and	   diastolic	   blood	   pressures	   have	   also	   been	   shown	   to	   be	   prognostic	  markers	  of	  CVD	  [108]	  and	  are	   independent	  risk	   factors	   for	  various	  cardiovascular	  events	  [88].	   	   While	   some	   articles	   have	   shown	   no	   improvements	   in	   blood	   pressure	   readings	  following	   HIIT	   [98,	   109],	   one	   study	   disagreed	   [22].	   	   Whyte	   et	   al.	   showed	   significant	  reductions	  in	  systolic	  blood	  pressure	  following	  two	  weeks	  of	  Wingate-­‐based	  HIIT	  [22].	  	  The	  differences	  between	  these	  studies	   lie	  within	   the	  subject	  population.	   	  Studies	   that	  showed	  no	   significant	   changes	   in	   blood	   pressure	   consisted	   of	   subjects	   who	   were	   healthy,	   but	  sedentary	  at	  the	  beginning	  of	  the	  intervention.	  	  On	  the	  other	  hand,	  the	  subjects	  used	  in	  the	  Whyte	  et	  al.	  paper	  were	  classified	  as	  overweight	  or	  obese	  before	  beginning	  the	  HIIT.	  	  These	  data	   suggests	   that	  healthy	   subjects	  may	  not	   see	   an	   altered	  blood	  pressure	   following	   this	  type	  of	  training,	  but	  overweight	  or	  obese	  subjects	  may	  see	  significant	  improvements.	  Left	   ventricular	   remodeling	   can	  be	   seen	   following	   three	  weeks	  of	   aerobic	   interval	  training	   [20].	   	   This	   is	   shown	   via	   levels	   of	   plasma	   proBNP,	   a	  marker	   of	   hypertrophy	   and	  severity	  of	  heart	  failure.	  	  The	  subjects	  in	  this	  study	  were	  post-­‐myocardial	  infarction.	  	  Along	  with	  lower	  levels	  of	  proBNP	  and	  improved	  ventricular	  morphology,	  Wisloff	  and	  colleagues	  observed	   reduced	   left	   ventricle	   end-­‐diastolic	   and	   end-­‐systolic	   volumes	   [20].	   	   Mentioned	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previously,	   the	  Wisloff	   paper	   is	   unique	   because	   they	   observed	   subjects	   from	   an	   elderly	  population	  who	  have	  previously	  experienced	  an	  adverse	  cardiac	  event.	  	  This	  study	  suggests	  that	  HIIT	  may	  be	  an	  effective	  replacement	  for	  endurance	  training,	  even	  in	  cardiac	  patients.	  Finally,	   a	   few	   studies	   observed	   overall	   quality	   of	   life	   following	   HIIT	   and	   showed	  significant	   improvements	   [17,	   20,	   110].	   	   The	   similarities	   between	   these	   three	   studies	   lie	  within	   the	   subject	   population	   as	   each	   cohort	   of	   subjects	   had	   previously	   experienced	   a	  cardiac	   event.	   	   These	   measurements	   mirror	   and	   provide	   further	   support	   for	   the	  aforementioned	   physiological	   improvements.	   	   These	   studies	   suggest	   that	   pronounced	  physiological	   adaptations	   provided	   an	   improved	   exercise	   capacity	   and	   an	   overall	  improvement	  in	  quality	  of	  life.	  















	  The	   purpose	   of	   this	   study	  was	   to	   examine	   the	   hemostatic	   adaptations	   in	   healthy	  adult	   men	   following	   four	   and	   eights	   weeks	   in	   a	   high-­‐intensity	   interval	   training	   (HIIT)	  intervention.	   	   All	   procedures	   were	   reviewed	   and	   approved	   by	   the	   Institutional	   Review	  Board	  at	  Ball	  State	  University.	  
Subjects	  Twenty-­‐one	   apparently	   healthy	   men	   (age:	   25	   ±	   1	   yr.;	   BMI:	   26.7	   ±	   6.2	   kg/m2)	  voluntarily	   participated	   in	   the	   present	   study.	   	   Prior	   to	   participating	   in	   the	   study,	   all	  participants	   provided	   written	   informed	   consent	   and	   completed	   a	   brief	   health	   history	  questionnaire	  that	  was	  used	  to	  screen	  for	  conditions	  that	  may	  compromise	  the	  safety	  of	  the	  subject	   or	   the	   integrity	   of	   the	   data	   during	   participation	   in	   the	   study.	   	   Subjects	   were	  apparently	  healthy,	  non-­‐smoking,	   sedentary	  men	  between	  18	  and	  45	  years	  old.	   	   Subjects	  weighed	   at	   least	   50	   kg.	   	   In	   this	   study,	   sedentary	  was	   defined	   as	   participating	   in	   aerobic	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physical	  activity	  fewer	  than	  two	  days	  a	  week	  and	  less	  than	  30	  minutes	  a	  day	  within	  the	  past	  three	  months.	   	   Subjects	   were	   free	   from	   known	   cardiovascular	   or	  metabolic	   disease	   and	  excluded	   from	   the	   study	   if	   they	   possessed	   two	   of	  more	   risk	   factors	   or	  were	   considered	  “high	  risk”	  according	  the	  American	  College	  of	  Sports	  Medicine	  [88].	  	  	  
Recruitment	  Subjects	  for	  this	  study	  were	  recruited	  from	  the	  Ball	  State	  community	  through	  e-­‐mail,	  flyers,	  and	  word	  of	  mouth.	  	  Subjects	  were	  required	  to	  attend	  at	  least	  20	  of	  the	  24	  exercise	  training	   sessions	   and	   complete	   the	   intervention	   within	   a	   ten-­‐week	   period	   or	   they	   were	  excluded	  from	  analysis.	  	  A	  baseline	  blood	  sample	  was	  not	  collected	  from	  one	  subject	  due	  to	  technical	   complications.	   	   Two	   subjects	   dropped	   out	   following	   four	   weeks	   for	   personal	  reasons	   and	   one	   subject	   dropped	   after	   one	   training	   session	   due	   to	   personal	   reasons.	  	  Furthermore,	   the	   lack	   of	   hematocrit	   values	   from	   two	   subjects	   disallowed	   for	   plasma	  volume	  corrections	  and	  no	  fibrinogen	  calculations	  at	  4w	  and	  8w.	  
Experimental	  Design	  Subjects	   were	   asked	   to	   report	   to	   the	   Integrative	   Exercise	   Physiology	   Laboratory	  (IEPL)	  for	  data	  collection	  on	  three	  separate	  occasions,	  and	  for	  exercise	  training	  on	  twenty-­‐four	   separate	   occasions.	   	   Each	   data	   collection	   session	   involved	   a	   blood	   draw	   from	   an	  antecubital	   vein,	   and	   the	   exercise	   training	   sessions	   involved	   three	   to	   six	   bouts	   of	   a	  standardized	  Wingate	   test.	   	   The	   total	   time	   commitment	   for	  data	   collection	  was	   less	   than	  three	  hours,	  and	  exercise	  training	  required	  approximately	  twelve	  hours	  over	  eight	  weeks	  (total	  time	  commitment	  of	  15	  hours).	  	  	  
Data	  Collection	  Protocol:	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Data	  collection	  took	  place	  within	  one	  week	  prior	  to	  beginning	  the	  training	  program	  and	   one	   week	   after	   the	   program.	   	   To	   assess	   the	   time	   course	   of	   putative	   training	  adaptations,	   an	   additional	   data	   collection	   took	   place	   after	   the	   fourth	   week	   of	   training.	  	  Subjects	  were	  asked	  to	  abstain	  from	  exercise	  for	  24	  hours	  prior	  to	  data	  collection,	  as	  well	  as	   alcohol,	   caffeine,	   and	   food	   or	   drink	   (except	   water)	   for	   12	   hours	   prior.	   	   The	   data	  collection	  period	  began	  with	  15	  minutes	  of	  semi-­‐recumbent	  rest,	  after	  which	  a	  10-­‐ml	  blood	  sample	  was	  taken	  from	  an	  antecubital	  vein	  using	  clean	  venipuncture	  with	  minimal	  stasis.	  	  Following	   the	   blood	   draw,	   subjects	   were	   instructed	   to	   move	   to	   a	   plinth	   where	   they	  experienced	  10	  minutes	  of	  supine	  rest.	  	  At	  this	  point,	  two	  resting	  brachial	  blood	  pressures	  were	  obtained	  via	  auscultation	  using	  an	  aneroid	  sphygmomanometer,	  calibrated	  to	  a	  wall	  mounted	  mercury	  column.	  	  Resting	  heart	  rate	  was	  also	  calculated	  following	  10	  minutes	  of	  supine	  rest	  using	  an	  ECG	  tracing	  analyzed	  by	  the	  SphygmoCor	  (Itasca,	  IL).	  	  Other	  vascular	  measures	  were	  then	  collected	  and	  can	  be	  found	  in	  a	  separate	  manuscript.	  
Exercise	  Training:	  	  	  The	   subjects	   reported	   to	   the	   IEPL	   for	   exercise	   training	   three	  days/week	   for	   eight	  consecutive	  weeks.	  	  Subjects	  weight	  was	  recorded	  at	  the	  beginning	  of	  each	  week	  in	  order	  to	  set	  the	  proper	  intensity	  on	  the	  Monark	  cycle	  ergometer.	  	  Prior	  to	  each	  training	  session	  the	  subjects	  warmed	  up	  with	  five	  minutes	  of	  cycling	  at	  50	  watts.	  	  	  Each	  training	  bout	  consisted	  of	  30	  seconds	  of	  high-­‐intensity	  cycling	  followed	  by	  4.5	  minutes	  of	  active	  recovery.	  	  During	  the	  first	  two	  weeks,	  training	  sessions	  included	  three	  bouts	  of	  cycling.	  	  With	  each	  successive	  two-­‐week	  period,	  an	  additional	  bout	  was	  added	  to	  the	  training	  session,	  so	  that	  four	  bouts	  were	  performed	  per	  session	  in	  weeks	  3-­‐4,	  five	  bouts	  in	  weeks	  5-­‐6,	  and	  six	  bouts	  in	  weeks	  7-­‐8.	  	  The	  training	  bout	  was	  modeled	  after	  a	  standard	  Wingate	  anaerobic	  test	  [112].	  	  Briefly,	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the	  subject	  pedaled	  as	   fast	  as	  possible	  with	   the	  resistance	  on	   the	   flywheel	   set	   to	  7.5%	  of	  body	  weight	   in	  kg.	   	  Active	   recovery	  between	  bouts	   included	  walking	  or	   cycling	   at	   a	   self-­‐selected,	  low	  intensity.	  	  	  
Blood	  Sampling/Processing:	  	  	  Blood	  samples	  were	  immediately	  centrifuged	  for	  20	  min	  at	  2,750xg	  at	  4°C	  to	  obtain	  platelet-­‐poor	  plasma.	  	  Plasma	  was	  separated	  from	  the	  red	  blood	  cells	  and	  spun	  again	  for	  5	  min	   at	   2,750xg	   at	   4°C	   to	   assure	   platelet-­‐poor	   plasma.	   	   Plasma	   aliquots	  were	   frozen	   and	  stored	   at	   -­‐20°C	   until	   assayed.	   	   Clotting	   time	  measures	   (activated	   partial	   thromboplastin	  time	   [APTT]	   and	   prothrombin	   time	   [PT])	   and	   plasma	   concentrations	   of	   fibrinogen	  were	  assessed	   by	   a	   coagulometer	   (Start4®,	   Diagnostica	   Stago;	   Parsippany	   NJ)	   according	   to	  manufacturer	   specifications.	   	   Briefly,	   calcium	   chloride	   was	   added	   to	   plasma	   samples	   to	  initiate	   a	   clotting	   reaction.	   	   The	   interrupted	  motion	   of	   a	  magnetic	   stir	   implement	   due	   to	  fibrin	  formation	  was	  monitored	  to	  determine	  coagulation	  time.	  
Statistical	  Analysis	  All	   statistical	  analyses	  were	  conducted	  using	  SPSS	   for	  Windows	  (version	  22,	  SPSS,	  Chicago,	  IL).	   	  Subject	  characteristics	  (age,	  height)	  are	  depicted	  using	  descriptive	  statistics.	  Resting	  measures	  of	  body	  mass	  index,	  resting	  blood	  pressure,	  resting	  heart	  rate,	  and	  blood	  clotting	   parameters	   were	   analyzed	   at	   baseline,	   4-­‐week,	   and	   8-­‐week	   using	   repeated	  measures	   ANOVA	   with	   time	   points	   as	   the	   within-­‐subjects	   variable.	   	   Further,	   exercise	  training	   variables,	   mean	   power	   (MP),	   peak	   power	   (PP),	   and	   fatigue	   index	   (FI),	   were	  averaged	  for	  each	  week	  and	  analyzed	  using	  a	  repeated	  measures	  ANOVA	  with	  time	  points	  as	  the	  within-­‐subjects	  variable.	  	  All	  data	  was	  normally	  distributed	  according	  to	  the	  Shapiro-­‐Wilk	  test	  of	  normality.	  	  Greenhouse-­‐Geisser	  adjustments	  were	  used	  when	  Mauchly’s	  test	  of	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ABSTRACT	  High	   intensity	   interval	   training	   (HIIT)	   is	   a	  novel	  mode	  of	   exercise	   training	   that	  has	  been	  shown	   to	   improve	   several	   components	   of	   health	   in	   various	   healthy	   and	   diseased	  populations.	   	   Purpose:	   	   The	   purpose	   of	   the	   present	   study	   was	   to	   examine	   hemostatic	  adaptations	   in	   healthy	   adult	  men	   following	   four	   and	   eight	  weeks	   of	   a	  HIIT	   intervention.	  
Methods:	  Twenty-­‐one	  healthy	  but	  sedentary	  men	  (age:	  25	  ±	  5	  yrs;	  BMI:	  26.7	  ±	  6.2	  kg/m2)	  volunteered	   to	  participate	   in	   the	  present	   study.	   	   Subjects	   completed	   eight	  weeks	  of	  HIIT	  that	   included	   three	   to	   six	   ‘all	   out’	   Wingate	   tests	   three	   days/week.	   	   Overall	   blood	  coagulation	  was	  assessed	  at	  baseline,	   following	  four	  weeks,	  and	  following	  eight	  weeks	  by	  clotting	  times	  of	  activated	  partial	  thromboplastin	  time	  (APPT)	  and	  prothrombin	  time	  (PT),	  and	  plasma	  concentration	  of	  fibrinogen.	   	  Plasma	  was	  obtained	  from	  whole	  blood	  samples	  taken	  at	  rest.	   	  A	  repeated	  measures	  ANOVA	  was	  used	  to	  compare	  the	  overall	  coagulation	  potential.	  	  Significance	  was	  set	  to	  p	  <	  0.05.	  	  Results:	  There	  were	  no	  significant	  differences	  between	  resting	  heart	  rate,	  resting	  blood	  pressure,	  APTT	  (baseline:	  43.0	  ±	  5.4;	  4w:	  42.7	  ±	  5.1;	  8w:	  44.2	  ±	  6.2),	  and	  PT	  (baseline:	  13.0	  ±	  0.9;	  4w:	  12.9	  ±	  0.6;	  8w:	  13.1	  ±	  0.8),	  after	  4w	  or	  8w	   of	  HIIT.	   	   Fibrinogen	   concentrations	   significantly	   decreased	   from	  baseline	   to	   4w	   (p	   <	  0.05)	   and	   significantly	   increased	   from	   4w	   to	   8w	   (p	   <	   0.05).	   	   Conclusion:	   Although	  beneficial	   fibrinogen	   changes	  were	   seen	   following	   four	  weeks	   of	   training,	   these	   findings	  were	   reversed	   after	   eight	   weeks.	   	   These	   observations	   suggest	   that	   HIIT	   may	   elicit	  improvements	  in	  coagulation	  potential	  after	  four	  weeks,	  but	  continued	  training	  may	  lead	  to	  elevated	   coagulation	   and/or	   inflammation	   via	   fibrinogen,	   which	   is	   recognized	   as	   a	   key	  regulator	  of	  inflammation	  and	  disease.	  
Key	  Words:	  Hemostasis,	  Thrombosis,	  Coagulation,	  HIIT,	  Interval,	  Training	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INTRODUCTION	  Cardiovascular	  disease	  (CVD)	  remains	  the	  most	  common	  cause	  of	  death	  in	  the	  world	  today	  (27).	   	  CVD	  or	  a	  CVD-­‐related	  event	  accounted	   for	  24.2%	  of	   the	   total	  deaths	   in	  2010	  (27).	   	   It	   is	   well	   known	   that	   exercising	   regularly	  will	   help	   prevent	   CVD	   and	   several	   CVD	  complications	  (4,	  17).	  	  The	  majority	  of	  cardiovascular	  events,	  including	  approximately	  80%	  of	   acute	  myocardial	   infarctions,	   are	   initiated	   by	   a	   blood	   clot,	   or	   thrombus,	   that	   occludes	  arterial	  blood	  flow	  (3).	  	  The	  ability	  of	  one’s	  blood	  to	  clot,	  or	  the	  coagulation	  potential,	  has	  been	  directly	  related	  to	  the	  onset	  of	  CVD	  as	  a	  thrombus	  may	  occur	  (34).	  	  Such	  thrombotic	  events	   that	   cause	  an	   ischemic	  event	  are	  directly	   related	   to	   the	  balance	  of	   the	  hemostatic	  system	   (34).	   	   The	  prediction	  of	   coronary	   risk	   can	  be	  determined	  by	   several	   factors	   (e.g.,	  FVIII	  and	  fibrinogen)	  as	  these	  factors	  may	  promote	  a	  procoagulant	  state	  of	  the	  hemostatic	  system	   (4).	   	   It	   is	   theorized	   that	   exercise	   training	   reduces	   one’s	   overall	   coagulation	  potential,	  as	  this	  is	  one	  of	  the	  reasons	  that	  regular	  exercise	  is	  cardioprotective	  (43).	  Several	   previously	   published	   studies	   suggest	   ACSM’s	   standard	   exercise	  recommendation	   (2)	   inconsistently	   influences	   coagulation	   potential	   (10,	   13,	   18,	   22).	  	  Traditional	  aerobic	  exercise	  training	  may	  result	  in	  increased	  (15,	  21,	  37),	  decreased	  (7,	  18,	  22)	  or	  unchanged	  coagulation	  potential	   (11).	   	  These	  equivocal	   results	   related	   to	  exercise	  training	  support	  the	  need	  for	  further	  investigations	  of	  training	  regimens	  that	  may	  deviate	  from	  traditional	  recommendations.	   	  High-­‐intensity	   interval	  training	  (HIIT)	   involves	  short,	  intermittent	  bouts	  of	  vigorous	  physical	  activity,	  interspersed	  with	  brief	  periods	  of	  passive	  or	   low-­‐intensity	   active	   recovery.	   	   HIIT	   has	   been	   shown	   to	   improve	   markers	   of	   aerobic	  physical	  fitness	  in	  various	  healthy	  and	  diseased	  populations	  (23,	  25,	  26,	  40,	  42).	  	  Also,	  HIIT	  has	   been	   shown	   to	   improve	   endothelial	   function,	   resting	   blood	   pressure,	   and	   left	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ventricular	  morphology	  (23,	  41,	  42),	  each	  of	  which	  is	  related	  to	  coagulation	  potential	  (16,	  29,	  38).	  	  	  Previous	   research	   indicates	   that	   coagulation	   responses	   to	   acute	   exercise	   are	  intensity	  dependent	  (43),	   leading	  to	  the	  speculation	  that	  the	  moderate	  intensities	  used	  in	  traditional	  exercise	   training	  may	  not	   stimulate	   the	  hemostatic	   system	   in	   such	  a	  way	   that	  would	   lead	   to	   beneficial	   changes	   in	   coagulation	   potential.	   	   Despite	   the	   large	   body	   of	  evidence	   supporting	   the	   benefits	   of	   regular	   exercise	   and	   the	   known	   dose-­‐response	  relationship	   between	   activity	   and	   disease,	   there	   is	   no	   consensus	   regarding	   the	   required	  dose	   of	   exercise	   needed	   to	   promote	   desired	   physiological	   adaptations	   (12,	   20).	   	   Blood	  clotting	   adaptations	   following	   a	   HIIT	   regimen	   are	   unknown.	   	   Thus,	   the	   purpose	   of	   this	  study	  was	   to	   evaluate	   the	   effects	   of	   four	   and	   eight	  weeks	   of	   HIIT	   on	  measures	   of	   blood	  coagulation	   potential.	   	   It	   was	   hypothesized	   that	   following	   four	   and	   eight	   weeks	   of	   HIIT	  subjects	  would	  experience	  a	  reduced	  coagulation	  potential	  with	  regards	  to	  clotting	  times	  of	  activated	   partial	   thromboplastin	   time	   (APTT),	   prothrombin	   time	   (PT)	   and	   fibrinogen	  concentration.	  
METHODOLOGY	  All	   procedures	  were	   reviewed	  and	  approved	  by	   the	   Institutional	  Review	  Board	   at	  Ball	  State	  University.	  
Subjects	  Twenty-­‐one	   apparently	   healthy	   men	   (age:	   25	   ±	   1	   yr.;	   BMI:	   26.7	   ±	   6.2	   kg/m2)	  voluntarily	   participated	   in	   the	   present	   study.	   	   Prior	   to	   participating	   in	   the	   study,	   all	  participants	   provided	   written	   informed	   consent	   and	   completed	   a	   brief	   health	   history	  questionnaire	  that	  was	  used	  to	  screen	  for	  conditions	  that	  may	  compromise	  the	  safety	  of	  the	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subject	   or	   the	   integrity	   of	   the	   data	   during	   participation	   in	   the	   study.	   	   Subjects	   were	  apparently	   healthy,	   non-­‐smoking,	   sedentary	  men	   between	   18	   and	   45	   years	   old.	   	   In	   this	  study,	   sedentary	  was	  defined	  as	  participating	   in	  aerobic	  physical	   activity	   fewer	   than	   two	  days	  a	  week	  and	  less	  than	  30	  minutes	  a	  day	  within	  the	  past	  three	  months.	   	  Subjects	  were	  free	  from	  known	  cardiovascular	  or	  metabolic	  disease	  and	  excluded	  from	  the	  study	  if	  they	  possessed	   two	   of	   more	   risk	   factors	   or	   were	   considered	   “high	   risk”	   according	   to	   the	  American	  College	  of	  Sports	  Medicine	  (2).	  	  	  
Recruitment	  Subjects	  for	  this	  study	  were	  recruited	  from	  the	  Ball	  State	  community	  through	  e-­‐mail,	  flyers,	  and	  word	  of	  mouth.	  	  Subjects	  were	  required	  to	  attend	  at	  least	  20	  of	  the	  24	  exercise	  training	   sessions	   and	   complete	   the	   intervention	   within	   a	   ten-­‐week	   period	   or	   they	   were	  excluded	  from	  analysis.	  	  A	  baseline	  blood	  sample	  was	  not	  collected	  from	  one	  subject	  due	  to	  technical	   complications.	   	   Two	   subjects	   dropped	   out	   following	   four	   weeks	   for	   personal	  reasons	   and	   one	   subject	   dropped	   after	   one	   training	   session	   due	   to	   personal	   reasons.	  	  Furthermore,	   the	   lack	   of	   hematocrit	   values	   from	   two	   subjects	   disallowed	   for	   plasma	  volume	  corrections	  and	  no	  fibrinogen	  calculations	  at	  4w	  and	  8w.	  	  
Experimental	  Design	  Subjects	   were	   asked	   to	   report	   to	   the	   Integrative	   Exercise	   Physiology	   Laboratory	  (IEPL)	  for	  data	  collection	  on	  three	  separate	  occasions,	  and	  for	  exercise	  training	  on	  twenty-­‐four	   separate	   occasions.	   	   Each	   data	   collection	   session	   involved	   a	   blood	   draw	   from	   an	  antecubital	   vein,	   and	   the	   exercise	   training	   sessions	   involved	   three	   to	   six	   bouts	   of	   a	  standardized	  Wingate	   test.	   	   The	   total	   time	   commitment	   for	  data	   collection	  was	   less	   than	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three	  hours,	  and	  exercise	  training	  required	  approximately	  twelve	  hours	  over	  eight	  weeks	  (total	  time	  commitment	  of	  15	  hours).	  	  	  
Data	  Collection	  Protocol:	  	  Data	  collection	  took	  place	  within	  one	  week	  prior	  to	  beginning	  the	  training	  program	  and	  one	  week	  after	  the	  program.	   	  To	  assess	  the	  time	  course	  of	  putative	  training	   adaptations,	   an	   additional	   data	   collection	   took	   place	   after	   the	   fourth	   week	   of	  training.	  	  Subjects	  were	  asked	  to	  abstain	  from	  exercise	  for	  24	  hours	  prior	  to	  data	  collection,	  as	  well	  as	  alcohol,	  caffeine,	  and	  food	  or	  drink	  (except	  water)	  for	  12	  hours	  prior.	  	  The	  data	  collection	  period	  began	  with	  15	  minutes	  of	  semi-­‐recumbent	  rest,	  after	  which	  a	  10-­‐ml	  blood	  sample	  was	  taken	  from	  an	  antecubital	  vein	  using	  clean	  venipuncture	  with	  minimal	  stasis.	  	  Following	   the	   blood	   draw,	   subjects	   were	   instructed	   to	   move	   to	   a	   plinth	   where	   they	  experienced	  10	  minutes	  of	  supine	  rest.	  	  At	  this	  point,	  two	  resting	  brachial	  blood	  pressures	  were	  obtained	  via	  auscultation	  using	  an	  aneroid	  sphygmomanometer,	  calibrated	  to	  a	  wall	  mounted	   mercury	   column.	   	   Resting	   heart	   rate	   (RHR)	   was	   also	   calculated	   following	   10	  minutes	  of	  supine	  rest	  using	  an	  ECG	  tracing	  analyzed	  by	  the	  SphygmoCor	  (Itasca,	  IL).	  	  Other	  vascular	  measures	  were	  then	  collected	  and	  can	  be	  found	  in	  a	  separate	  manuscript.	  
Exercise	  Training:	  	  The	  subjects	  reported	  to	  the	  IEPL	  for	  exercise	  training	  three	  days/week	  for	  eight	  consecutive	  weeks.	  	  Subjects	  weight	  was	  recorded	  at	  the	  beginning	  of	  each	  week	  in	  order	  to	  set	  the	  proper	  intensity	  on	  the	  Monark	  cycle	  ergometer.	  	  Prior	  to	  each	  training	  session	   the	   subjects	  warmed	  up	  with	   five	  minutes	  of	   cycling	   at	  50	  watts.	   	   	   Each	   training	  bout	   consisted	   of	   30	   seconds	   of	   high-­‐intensity	   cycling	   followed	   by	   4.5	  minutes	   of	   active	  recovery.	   	   During	   the	   first	   two	  weeks,	   training	   sessions	   included	   three	   bouts	   of	   cycling.	  	  With	   each	   successive	   two-­‐week	   period,	   an	   additional	   bout	   was	   added	   to	   the	   training	  session,	  so	  that	  four	  bouts	  were	  performed	  per	  session	  in	  weeks	  3-­‐4,	  five	  bouts	  in	  weeks	  5-­‐
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6,	   and	   six	  bouts	   in	  weeks	  7-­‐8.	   	  The	   training	  bout	  was	  modeled	  after	   a	   standard	  Wingate	  anaerobic	  test	  (5).	  	  Briefly,	  the	  subject	  pedaled	  as	  fast	  as	  possible	  with	  the	  resistance	  on	  the	  flywheel	  set	  to	  7.5%	  of	  body	  weight	  in	  kg.	  	  Active	  recovery	  between	  bouts	  included	  walking	  or	  cycling	  at	  a	  self-­‐selected,	  low	  intensity.	  	  	  
Blood	   Sampling/Processing:	   	   Blood	   samples	   were	   immediately	   centrifuged	   for	   20	  min	   at	  2,750xg	  at	  4°C	  to	  obtain	  platelet-­‐poor	  plasma.	   	  Plasma	  was	  separated	  from	  the	  red	  blood	  cells	   and	   spun	  again	   for	  5	  min	  at	  2,750xg	   at	  4°C	   to	  assure	  platelet-­‐poor	  plasma.	   	  Plasma	  aliquots	  were	  frozen	  and	  stored	  at	  -­‐20°C	  until	  assayed.	  	  Clotting	  time	  measures	  (APTT	  and	  PT)	   and	   plasma	   concentrations	   of	   fibrinogen	  were	   assessed	   by	   a	   coagulometer	   (Start4®,	  Diagnostica	   Stago;	   Parsippany,	   NJ)	   according	   to	   manufacturer	   specifications.	   	   Briefly,	  calcium	   chloride	   was	   added	   to	   plasma	   samples	   to	   initiate	   a	   clotting	   reaction.	   	   The	  interrupted	  motion	  of	  a	  magnetic	  stir	  implement	  due	  to	  fibrin	  formation	  was	  monitored	  to	  determine	  coagulation	  time.	  
Statistical	  Analysis	  All	   statistical	  analyses	  were	  conducted	  using	  SPSS	   for	  Windows	  (version	  22,	  SPSS,	  Chicago,	  IL).	   	  Subject	  characteristics	  (age,	  height)	  are	  depicted	  using	  descriptive	  statistics.	  Resting	   measures	   of	   body	   mass	   index	   (BMI),	   resting	   blood	   pressure,	   RHR,	   and	   blood	  clotting	   parameters	   were	   analyzed	   at	   baseline,	   4-­‐week,	   and	   8-­‐week	   using	   repeated	  measures	   ANOVA	   with	   time	   points	   as	   the	   within-­‐subjects	   variable.	   	   Further,	   exercise	  training	   variables,	   mean	   power	   (MP),	   peak	   power	   (PP),	   and	   fatigue	   index	   (FI),	   were	  averaged	  for	  each	  week	  and	  analyzed	  using	  a	  repeated	  measures	  ANOVA	  with	  time	  points	  as	  the	  within-­‐subjects	  variable.	  	  All	  data	  was	  normally	  distributed	  according	  to	  the	  Shapiro-­‐Wilk	  test	  of	  normality.	  	  Greenhouse-­‐Geisser	  adjustments	  were	  used	  when	  Mauchly’s	  test	  of	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sphericity	  was	  significant	  (p	  <	  0.05).	  	  Significant	  statistical	  analyses	  were	  followed	  up	  using	  the	  Fisher’s	  LSD	  test.	   	  The	  following	  variables	  were	   included	  in	  the	  analyses:	  MP	  (W);	  PP	  (W);	  FI	  (%);	  APTT	  (sec);	  PT	  (sec);	  and	  plasma	  concentrations	  of	  fibrinogen	  (mg/dL).	  	  Four-­‐week	  and	  eight-­‐week	  fibrinogen	  concentrations	  were	  corrected	  for	  plasma	  volume	  changes	  using	  the	  VanBeaumont	  equation	  (36).	  	  Statistical	  significance	  was	  set	  at	  alpha	  <	  0.05.	  
RESULTS	  
Subjects	  	   All	   results	   are	   expressed	   at	   means	   ±	   SD.	   	   Twenty-­‐one	   men	   volunteered	   for	   this	  study.	  	  Subjects	  were	  25	  ±	  5	  yrs	  old	  and	  178.2	  ±	  10.0	  cm	  tall.	  	  Demographic	  information	  for	  each	  time	  point	  (baseline,	  4w,	  and	  8w)	  is	  presented	  in	  Table	  1.	  	  There	  were	  no	  significant	  differences	   between	   time	  points	   for	   age,	   height,	  weight,	   BMI,	  RHR,	   resting	   systolic	   blood	  pressure	  (SBP),	  and	  resting	  diastolic	  blood	  pressure	  (DBP).	  	  
Exercise	  Training	  	   Weekly	   averages	   of	   PP,	   MP,	   and	   FI	   decreased	   significantly	   over	   the	   eight-­‐week	  training	  period	  (p	  <	  0.05).	  	  MP	  and	  PP	  weekly	  averages	  can	  be	  seen	  in	  Table	  2.	  	  FI	  weekly	  averages	  can	  be	  seen	  in	  Figure	  1.	  
Blood	  Coagulation	  	   Blood	  clotting	  measures	  of	  APTT	  and	  PT	  were	  unchanged	  between	   the	   three	   time	  points	  and	  can	  be	  seen	  in	  Table	  1.	  	  Baseline,	  4w,	  and	  8w	  values	  for	  the	  INR	  of	  PT	  were	  0.79,	  0.78,	  and	  0.78,	  respectively,	  and	  not	  significantly	  different	  between	  time	  points.	  	  When	  the	  plasma	   was	   analyzed	   for	   fibrinogen	   concentrations,	   significant	   differences	   were	   evident	  between	  baseline	   and	  4w	  measures	   (p	  =	  0.037)	   and	  between	  4w	  and	  8w	  measures	   (p	  =	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0.024).	  However,	   there	  were	  no	  significant	  differences	  between	  plasma	  concentrations	  of	  fibrinogen	  between	  baseline	  and	  8w.	  	  Fibrinogen	  values	  are	  presented	  in	  Figure	  2.	  	  	  
DISCUSSION	  The	  major	   finding	  was	   that	   fibrinogen	   levels	  were	   significantly	   lower	   after	   4w	   of	  HIIT	   compared	   to	   baseline,	   and	   significantly	   increasing	   over	   the	   remaining	   weeks	   of	  training,	   essentially	   returning	   to	   baseline	   levels.	   	   The	   significant	   decrease	   in	   fibrinogen	  from	   baseline	   to	   4w	   supports	   our	   hypothesis	   that	   HIIT	   would	   cause	   a	   reduction	   in	  coagulation	   potential.	   	   Previous	   research	   indicates	   that	   fibrinogen	   levels	   are	   decreased	  following	   intense	  physical	   training	   (13,	  33,	  44).	  However,	   the	   rise	   in	   fibrinogen	  after	   the	  eighth	  week	  of	  training	  (back	  to	  baseline	  levels)	  is	  not	  supported	  by	  our	  hypothesis.	  	  While	  this	  significant	  increase	  in	  fibrinogen	  levels	  was	  unexpected,	  it	  has	  previously	  been	  seen	  in	  the	   literature	   (24,	   30,	   32).	   	   The	   increase	   in	   fibrinogen	   levels	   may	   be	   explained	   by	   the	  substantial	  increase	  in	  volume	  of	  exercise	  training	  that	  occurred	  in	  the	  latter	  four	  weeks	  of	  training	  compared	  to	  the	  first	  four	  weeks	  of	  training.	  Several	  studies	  have	  examined	  plasma	  fibrinogen	  concentrations	  following	   intense	  physical	  training	  programs	  and	  a	  few	  studies	  showed	  fibrinogen	  levels	  to	  increase	  (24,	  30).	  	  Ponjee	   et	   al.	   conducted	   a	   study	   in	   1993	   that	   showed	   similar	   results	   to	   our	   study	   (30).	  	  While	  the	  training	  regimen	  was	  unique	  in	  the	  aspect	  that	  the	  subjects	  were	  training	  for	  a	  half-­‐marathon	   race,	   they	   showed	   an	   initial	   decrease	   in	   fibrinogen	   levels	   followed	   by	   a	  significant	  increase	  in	  fibrinogen	  levels	  that	  mirrored	  the	  increase	  in	  training	  volume	  and	  intensity.	   	  Sedentary	  men	  and	  women	  trained	  at	  increasing	  intensities	  and	  volumes	  for	  9-­‐months	   in	   preparation	   for	   a	   race	   via	   long-­‐distance	   running,	   running	   at	   high	   speeds,	   and	  interval	  training.	   	  Similarly,	  another	  study	  showed	  an	  increase	  in	  fibrinogen	  in	  male	  army	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recruits	  following	  10	  weeks	  of	  basic	  training	  (24).	   	  Although	  not	  specified	  in	  depth	  in	  the	  paper,	   one	   may	   expect	   the	   exercise	   protocol	   of	   basic	   training	   camp	   to	   be	   of	   extreme	  vigorous	   intensity	   and	   of	   high	   volume.	   	   Combining	   these	   results	   and	   the	   results	   of	   the	  present	   study,	   it	   is	   suggested	   that	   fibrinogen	   levels	   may	   decrease	   following	   general	  exercise	   prescription	   but	   may	   increase	   with	   a	   high	   intensity	   and/or	   volume	   of	   exercise	  training.	  The	  observed	  changes	  in	  fibrinogen	  levels	  in	  the	  present	  study	  may	  be	  related	  to	  the	  fact	   that	   fibrinogen	   is	   an	   acute	   phase	   reactant	   protein.	   	   This	   indicates	   that	   plasma	  concentrations	   of	   fibrinogen	   will	   increase	   or	   decrease	   parallel	   to	   inflammation.	  	  Furthermore,	   previous	   research	   has	   demonstrated	   that	   intense	   physical	   training	  exacerbates	   inflammation	   (28).	   	   In	   pathological	   conditions,	   such	   as	   injury	   or	   diseases	  associated	  with	  vascular	  disruption,	  fibrinogen	  levels	  have	  been	  shown	  to	  increase	  several	  fold	   (1).	   	  While	   its	   role	   in	   the	   coagulation	   cascade	   is	  well	   established,	   a	   growing	  body	  of	  evidence	   implicates	   fibrinogen	   concentration	   as	   a	   key	   regulator	   of	   inflammation	   (9).	  	  Davalos	   &	   Akassoglou	   discuss	   how	   our	   understanding	   of	   fibrinogen	   is	   evolving	   from	   a	  building	  block	  of	  blood	  clots	   to	  an	  essential	   signaling	  molecule	  with	  a	  broad	  spectrum	  of	  functions,	   including	   extensive	   inflammation,	   eventually	   leading	   to	   life	   or	   death	   (9).	  	  Fibrinogen	  signaling	  is	  becoming	  more	  and	  more	  evident	  through	  its	  binding	  sites	  that	  are	  non-­‐overlapping	   with	   those	   in	   the	   coagulation	   cascade	   (9).	   	   With	   the	   perspective	   that	  fibrinogen	  levels	  are	  related	  to	  inflammation,	  our	  data	  suggest	  that	  the	  first	  four	  weeks	  of	  training	   in	   this	   study	   did	   not	   cause	   chronic	   inflammation	   and	   therefore	   significantly	  reduced	  fibrinogen	  levels.	  	  This	  is	  comparable	  to	  what	  is	  seen	  in	  the	  literature	  with	  regards	  to	   traditional,	   aerobic	   exercise	   training	   (13,	   44).	   	  However,	  when	   the	   volume	  of	   exercise	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was	   ramped	   up	   (latter	   four	   weeks),	   it	   is	   theorized	   that	   chronic	   inflammation	   was	  stimulated,	  leading	  to	  a	  significant	  rise	  in	  fibrinogen	  levels	  through	  its	  several	  binding	  sites	  as	  it	  acts	  as	  a	  mediator	  of	  inflammatory	  disease.	  	  	  	   While	  the	  rise	   in	  fibrinogen	  levels	  observed	  in	  the	  final	   four	  weeks	  of	  this	  study	  is	  still	   important	   with	   regards	   to	   thrombosis,	   it	   is	   postulated	   that	   this	   adaptation	   did	   not	  directly	  affect	  the	  coagulation	  cascade,	  a	  hypothesis	  that	  is	  supported	  by	  the	  results	  of	  the	  clotting	  time	  analyses.	  	  Unlike	  fibrinogen,	  no	  significant	  differences	  were	  found	  with	  regard	  to	  APTT	  between	  baseline,	  4w,	  and	  8w.	  	  Previously	  published	  articles	  showed	  APTT	  either	  increases	   (18,	   35)	   or	   decreases	   (37,	   39)	   with	   exercise	   training.	   	   With	   the	   significant	  changes	   in	   fibrinogen	   levels,	   one	  may	   expect	   to	   see	   APTT	   levels	   change	   as	  well	   because	  fibrinogen	   is	   a	   part	   of	   the	   coagulation	   cascade’s	   intrinsic	   pathway,	   which	   is	   evaluated	  during	   an	  APTT	   test.	   	   However,	   a	   change	   in	   fibrinogen	   levels	   does	   not	   always	   affect	   the	  coagulation	   cascade.	   	  While	   fibrinogen	   levels	   increased	   in	   our	   subjects,	   it	   may	   not	   have	  actually	   affected	   coagulation	   activity,	   as	   APTT’s	   did	   not	   change	   over	   the	   entirety	   of	   the	  study.	  	   Similarly	  to	  APTT,	  no	  significant	  difference	  was	  found	  in	  PT	  between	  baseline,	  4w,	  and	  8w.	  	  However,	  contrary	  to	  the	  measure	  of	  APTT,	  a	  PT	  test	  does	  not	  assess	  the	  portion	  of	  the	  coagulation	  cascade	  in	  which	  fibrinogen	  plays	  a	  role.	  	  The	  fact	  that	  PT	  did	  not	  change	  throughout	  the	  training	  program	  is	  shown	  in	  the	  literature	  and	  confirmed	  with	  this	  study.	  	  Several	  investigations	  in	  the	  past	  have	  analyzed	  PT’s	  and	  shown	  that	  exercise	  training	  does	  not	   affect	   it	   (15,	   19,	   35,	   39).	   	   These	   studies	   encompassed	   different	  modes	   and	   different	  volumes	   of	   exercise	   as	   well	   as	   different	   populations	   of	   subjects.	   	   This	   finding,	   which	   is	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comparable	   to	  what	   is	   seen	   in	   the	   literature,	   suggests	   that	   the	  extrinsic	  pathway	   is	  not	  a	  modulator	  in	  the	  coagulation	  changes	  associated	  with	  exercise	  training.	  	  	   A	   limitation	   of	   this	   study	   was	   our	   subject	   population	   of	   college-­‐aged	   men.	  	  Coagulation	  parameters	  differ	  significantly	  based	  on	  the	  population	  of	  the	  cohort	  and	  our	  subject	   population	  may	  not	   be	   generalizable	   to	   the	   other	   populations.	   	   It	   is	   thought	   that	  clinical	   and	   cardiac	   populations	   that	  may	   already	   have	   an	   elevated	   inflammation	   and/or	  coagulation	  potential	  might	  experience	  something	  different	  during	  HIIT.	  Another	  limitation	  of	  this	  study	  lies	  within	  the	  fact	  that	  we	  did	  not	  objectively	  measure	  a	  training	  adaptation.	  	  While	  it	  is	  believed	  that	  a	  training	  adaptation	  occurred,	  no	  improvements	  were	  shown	  via	  a	  Wingate	  test.	   	  Therefore,	   future	  research	  may	  want	  to	  measure	  training	  adaptations	  via	  a	  single	  Wingate	  test	  or	  VO2	  max	  test	  before	  and	  after	  the	  training	  program.	  	  Finally,	  the	  lack	  of	   a	   non-­‐exercise	   or	   endurance	   training	   control	   group	   may	   have	   limited	   our	   ability	   to	  observe	  significant	  adaptations	  to	  HIIT.	  Future	  research	  should	  focus	  on	  the	  goal	  to	  elucidate	  the	  volume	  of	  HIIT	  required	  to	  elicit	  beneficial	  improvements	  in	  blood	  clotting	  parameters.	  	  Specifically,	  it	  is	  important	  to	  find	   the	   volume	   and	   intensity	   of	   an	   exercise	   training	   program	   that	   yields	   the	   most	  beneficial	  values	  with	  regards	  to	   fibrinogen.	   	  Careful	   investigations	  need	  to	  be	  conducted	  with	   regards	   to	   the	   putative	   time	   course	   of	   adaptations	   and	   exercise	   intensity/volume.	  	  Several	  studies	  used	  six	  weeks	  of	  HIIT	  and	  showed	  positive	  changes	  (6,	  31),	  but	  our	  eight	  week	  study	  did	  not	  concur.	  	  It	  is	  also	  suggested	  that	  future	  investigations	  extend	  HIIT	  into	  10,	   12,	   and	   more	   weeks	   to	   analyze	   the	   occurring	   adaptations.	   	   Furthermore,	   future	  research	   should	   explore	   inflammation	   in	   response	   to	   HIIT	   including	   other	   markers	   of	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inflammation	   such	   as	   interleukin-­‐6,	   C-­‐reactive	   protein,	   interleukin-­‐1,	   and/or	   adhesion	  molecules.	  
CONCLUSION	  	   In	   conclusion,	   the	   present	   study	   indicates	   that	   a	   four-­‐week	   HIIT	   program	   may	  reduce	   fibrinogen	   levels,	   but	   an	   additional	   four	  weeks	   of	   HIIT	   brought	   fibrinogen	   levels	  back	  to	  baseline	  values.	   	   It	   is	  unclear	   if	  continued	  HIIT	  would	  provoke	   further	   fibrinogen	  increases.	   	  This	   study	  elicited	  no	  change	   in	  APTT	  and	  PT	  values	   following	   four	  and	  eight	  weeks	  of	  HIIT.	  It	  is	  believed	  that	  blood	  clotting	  potential	  wasn’t	  affected	  and	  that	  fibrinogen	  changes	  were	  due	  to	  an	  inflammatory	  response.	  	  While	  fibrinogen	  is	  an	  important	  marker	  of	  blood	  clotting	   in	  the	  coagulation	  cascade,	   it	   is	  becoming	  a	  more	   important	  mediator	  of	  inflammatory	   disease	   (9).	   	   Increased	   fibrinogen	   levels	   are	   commonly	   found	   in	   cardiac	  patients,	  and	  are	  an	  important	  risk	  factor	  for	  stroke	  (8,	  14).	  	  This	  suggests	  that,	  because	  of	  HIIT’s	   ability	   to	   induce	   inflammation,	   HIIT	   may	   be	   dangerous	   for	   those	   with	   increased	  levels	  of	  fibrinogen	  and	  should	  be	  avoided	  by	  subjects	  at	  risk.	  	  Results	  of	  this	  study	  may	  be	  important	  for	  medical	  and	  exercise	  professionals	  who	  work	  with	  individuals	  with	  elevated	  inflammation	  and	  high	  thrombotic	  risk.	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Table	  1.	  Resting	  Measures	  and	  Blood	  Clotting	  Times	  
	   Baseline	   4w	   8w	  
Weight	  (kg)	   85.2	  ±	  21.1	   85.8	  ±	  21.2	   86.2	  ±	  21.1	  
BMI	  (kg/m2)	   26.7	  ±	  6.2	   26.9	  ±	  6.3	   26.9	  ±	  6.3	  
RHR	  (bpm)	   56.7	  ±	  11.2	   55.4	  ±	  7.7	   54.7	  ±	  9.0	  
SBP	  (mmHg)	   111.2	  ±	  10.9	   111.4	  ±	  12.6	   109.3	  ±	  10.9	  
DBP	  (mmHg)	   67.8	  ±	  8.8	   69.4	  ±	  11.3	   68.3	  ±	  8.4	  
APTT	  (sec)	   43.0	  ±	  5.4	   42.7	  ±	  5.1	   44.2	  ±	  6.2	  
PT	  (sec)	   13.0	  ±	  0.9	   12.9	  ±	  0.6	   13.1	  ±	  0.8	  Resting	  measures	  and	  measures	  of	  blood	  clotting	   times	  are	  presented	  as	  mean	  ±	  SD	  (n	  =	  18).	  	  No	  significant	  differences	  were	  seen	  between	  any	  of	  the	  time	  points	  (p	  >	  0.05).	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TABLE	  2	  	  
Table	  2.	  Training	  Stimulus	  of	  Mean	  Power	  and	  Peak	  Power	  
	   MP	  (W)	   PP	  (W)	  
Week	  1	   511.7	  ±	  132.0	   749.8	  ±	  205.4	  
Week	  2	   519.6	  ±	  132.9	   753.2	  ±	  212.0	  
Week	  3	   512.4	  ±	  123.5	   720.3	  ±182.2	  
Week	  4	   514.0	  ±	  121.4	   712.2	  ±	  183.4	  
Week	  5	   497.5	  ±	  112.7	   694.0	  ±	  183.8	  
Week	  6	   505.0	  ±	  114.2	   708.1	  ±	  200.0	  
Week	  7	   493.9	  ±	  112.6	   683.2	  ±	  197.2	  
Week	  8	   490.9	  ±	  119.6	   665.6	  ±	  183.6	  Average	   weekly	   mean	   power	   and	   peak	   power	   values	   over	   the	   eight	   weeks	   of	   exercise	  training	  presented	  as	  mean	  ±	  SD	  (n	  =	  18).	  	  Mean	  power	  and	  peak	  power	  were	  significantly	  reduced	  over	  the	  training	  program	  (p	  <	  0.05).	  




Figure	  1.	  Training	  Stimulus	  of	  Fatigue	  Index	  
	  Average	  fatigue	  index	  for	  each	  week	  over	  the	  eight	  weeks	  of	  exercise	  training	  presented	  as	  mean	  ±	  SD.	  	  Fatigue	  index	  was	  significantly	  reduced	  over	  the	  training	  program	  (p	  <	  0.05).	  




















Figure	  2.	  Fibrinogen	  Concentrations	  
	  Fibrinogen	   levels	   at	   baseline,	   4w,	   and	   8w	   of	   HIIT	   presented	   as	  mean	   ±	   SD.	   	   Fibrinogen	  concentrations	  were	  significantly	  decreased	  at	  4w	  compared	  to	  baseline	  and	  8w	  (p	  <	  0.05).	  
	  







































Discussion	  The	  purpose	  of	  the	  present	  study	  was	  to	  examine	  changes	  to	  the	  hemostatic	  system	  before,	   during,	   and	   after	   an	   eight	   week	   HIIT	   intervention.	   	   The	   major	   finding	   was	   that	  fibrinogen	   levels	   were	   significantly	   lower	   after	   4w	   of	   HIIT	   compared	   to	   baseline,	   and	  significantly	   increasing	   over	   the	   remaining	   weeks	   of	   training,	   essentially	   returning	   to	  baseline	   levels.	   	   The	   significant	  decrease	   in	   fibrinogen	   from	  baseline	   to	  4w	   supports	  our	  hypothesis	  that	  HIIT	  would	  cause	  a	  reduction	  in	  coagulation	  potential.	   	  Previous	  research	  indicates	   that	   fibrinogen	   levels	   are	   decreased	   following	   intense	   physical	   training	   [9,	   73,	  74].	   However,	   the	   rise	   in	   fibrinogen	   after	   the	   eighth	   week	   of	   training	   (back	   to	   baseline	  levels)	   is	   not	   supported	   by	   our	   hypothesis.	   	  While	   this	   significant	   increase	   in	   fibrinogen	  levels	  was	  unexpected,	  it	  has	  previously	  been	  seen	  in	  the	  literature	  [75-­‐77].	  	  The	  increase	  in	   fibrinogen	   levels	   may	   be	   explained	   by	   the	   substantial	   increase	   in	   volume	   of	   exercise	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training	  that	  occurred	  in	  the	  latter	  four	  weeks	  of	  training	  compared	  to	  the	  first	  four	  weeks	  of	  training.	  Several	  studies	  have	  examined	  plasma	  fibrinogen	  concentrations	  following	   intense	  physical	  training	  programs	  and	  fibrinogen	  levels	  were	  shown	  to	  decrease	  [9,	  74],	  increase	  [76,	  77],	  or	  not	   change	   [78,	  79]	  with	  different	  modes	  of	   training.	   	  Most	  of	   the	  previously	  mentioned	  training	  regimens	  that	  showed	  a	  decrease	  in	  fibrinogen	  levels	  entailed	  subjects	  who	   may	   have	   had	   increased	   levels	   of	   fibrinogen	   before	   the	   exercise	   training	   program	  because	   of	   links	   to	   obesity	   and/or	   previous	   cardiac	   events.	   	   Likewise,	   because	   of	   the	  increase	   in	   training	   volume,	   compared	   to	   normal	   everyday	   activity,	   those	   subjects	  experienced	   decreased	   fibrinogen	   levels.	   	   On	   the	   other	   hand,	   Ponjee	   et	   al.	   conducted	   a	  study	   in	  1993	   that	   showed	  similar	   results	   to	  our	  study	   [77].	   	  While	   the	   training	  regimen	  was	   unique	   in	   the	   aspect	   that	   the	   subjects	   were	   training	   for	   a	   half-­‐marathon	   race,	   they	  showed	   an	   initial	   decrease	   in	   fibrinogen	   levels	   followed	   by	   a	   significant	   increase	   in	  fibrinogen	   levels	   that	  mirrored	   the	   increase	   in	   training	  volume	  and	   intensity.	   	   Sedentary	  men	  and	  women	  trained	  at	  increasing	  intensities	  and	  volumes	  for	  9-­‐months	  in	  preparation	  for	   a	   race	   via	   long-­‐distance	   running,	   running	   at	   high	   speeds,	   and	   interval	   training.	   	   An	  initial	  decrease	   in	   fibrinogen	   levels	   is	  seen	  at	  13	  weeks	  of	   training	   followed	  by	  a	  gradual	  increase	   in	   fibrinogen	   levels	  all	   the	  way	   through	  the	  end	  of	   the	  study.	   	  Similarly,	  another	  study	  showed	  an	  increase	  in	  fibrinogen	  in	  male	  army	  recruits	  following	  10	  weeks	  of	  basic	  training	   [76].	   	  Although	  not	   specified	   in	  depth	   in	   the	  paper,	  one	  may	  expect	   the	  exercise	  protocol	   of	   basic	   training	   camp	   to	   be	   of	   extreme	   vigorous	   intensity	   and	   of	   high	   volume.	  	  Combining	  these	  results	  and	  the	  results	  of	  the	  present	  study,	  it	  is	  suggested	  that	  fibrinogen	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levels	  may	  decrease	  following	  a	  moderate	  intensity	  and/or	  volume	  of	  exercise	  training	  but	  may	  increase	  following	  a	  high	  intensity	  and/or	  volume	  of	  exercise	  training.	  The	  observed	  changes	  in	  fibrinogen	  levels	  in	  the	  present	  study	  may	  be	  related	  to	  the	  fact	   that	   fibrinogen	   is	   an	   acute	   phase	   reactant	   protein.	   	   This	   indicates	   that	   plasma	  concentrations	   of	   fibrinogen	   will	   increase	   or	   decrease	   parallel	   to	   inflammation.	  	  Furthermore,	   previous	   research	   has	   demonstrated	   that	   intense	   physical	   training	  exacerbates	  inflammation	  [114].	  	  Plasma	  concentrations	  of	  fibrinogen	  generally	  range	  from	  200	  to	  400	  mg/dL	  [115],	  and	  fibrinogen	  levels	  in	  the	  present	  study	  remained	  within	  range	  throughout.	  	  In	  pathological	  conditions,	  such	  as	  injury	  or	  diseases	  associated	  with	  vascular	  disruption,	  fibrinogen	  levels	  have	  been	  shown	  to	  increase	  several-­‐fold	  [116].	  	  While	  its	  role	  in	   the	   coagulation	   cascade	   is	   well	   established,	   a	   growing	   body	   of	   evidence	   implicates	  fibrinogen	  concentration	  as	  a	  key	  regulator	  of	  inflammation	  [117].	  	  An	  in	  depth	  review	  by	  Davalos	   &	   Akassoglou	   discuss	   how	   our	   understanding	   of	   fibrinogen	   is	   evolving	   from	   a	  building	  block	  of	  blood	  clots	   to	  an	  essential	   signaling	  molecule	  with	  a	  broad	  spectrum	  of	  functions,	   including	   extensive	   inflammation,	   eventually	   leading	   to	   life	   or	   death	   [117].	  	  Fibrinogen	  signaling	  is	  becoming	  more	  and	  more	  evident	  through	  its	  binding	  sites	  that	  are	  non-­‐overlapping	  with	   those	   in	   the	   coagulation	   cascade	   [117].	   	  With	   the	   perspective	   that	  fibrinogen	  levels	  are	  related	  to	  inflammation,	  our	  data	  suggest	  that	  the	  first	  four	  weeks	  of	  training	   in	   this	   study	   did	   not	   cause	   chronic	   inflammation	   and	   therefore	   significantly	  reduced	  fibrinogen	  levels.	  	  This	  is	  comparable	  to	  what	  is	  seen	  in	  the	  literature	  with	  regards	  to	  traditional,	  aerobic	  exercise	  training	  [9,	  73].	   	  However,	  when	  the	  volume	  of	  exercise	   is	  ramped	  up	   (latter	   four	  weeks),	   it	   is	   theorized	   that	   chronic	   inflammation	  was	   stimulated,	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leading	  to	  a	  significant	  rise	  in	  fibrinogen	  levels	  through	  its	  several	  binding	  sites	  as	  it	  acts	  as	  a	  mediator	  of	  inflammatory	  disease.	  	  	  It	   is	   important	   to	   further	   understand	   the	   relationship	   between	   inflammation	   and	  exercise	   training	   because	   of	   the	   positive	   relationship	   between	   the	   several	   markers	   of	  inflammation	  and	  the	  risk	  for	  an	  adverse	  cardiovascular	  event	  in	  both	  healthy	  and	  diseased	  populations	  [118,	  119].	  	  One	  of	  the	  reasons	  that	  exercise	  training	  is	  shown	  to	  be	  beneficial	  to	  overall	  health	  is	  because	  it	  is	  known	  to	  attenuate	  inflammation	  [120]	  and	  the	  literature	  is	  convincing	  with	  regards	  to	  the	  idea	  that	  inflammation	  and	  exercise	  are	  inversely	  related	  [69,	   79,	   121-­‐124].	   	   Previously	   published	   studies	   observe	   several	   important	   markers	   of	  inflammation	   including	   fibrinogen,	   C-­‐reactive	   protein,	   interleukin-­‐6,	   and	   adhesion	  molecules.	  	  	  Koenig	  and	  colleagues	  conducted	  an	  eight-­‐year	  study	  and	  concluded	  that	  C-­‐reactive	  protein	   is	   a	   sensitive	   systemic	   marker	   of	   inflammation	   and	   related	   to	   physical	   activity	  [121].	  	  C-­‐reactive	  protein	  levels	  were	  positively	  correlated	  with	  the	  incidence	  of	  an	  adverse	  cardiovascular	   event.	   	   Due	   to	   the	   length	   of	   this	   study,	   subjects	  were	   of	   various	   levels	   of	  fitness	   and	   some	   fitness	   levels	   changed	   drastically	   over	   the	   time	   period	   of	   the	   study.	  	  Likewise,	   Rohde	   et	   al.	   conducted	   a	   few	   studies	   that	   showed	   that	   C-­‐reactive	   protein	   and	  interleukin-­‐6	  are	  good	  prognostic	  markers	  of	  inflammation	  with	  regard	  to	  exercise	  training	  and	   in	   turn	   related	   to	   the	   risk	   of	   an	   adverse	   cardiovascular	   event	   [122,	   123].	   	   While	  observing	  an	  elderly	  cohort,	  another	  study	  showed	  an	  inverse	  relationship	  between	  several	  inflammatory	  markers	  (e.g.,	  fibrinogen,	  FVIII,	  C-­‐reactive	  protein)	  and	  physical	  activity	  [69].	  	  On	  the	  other	  hand,	  a	  study	  done	  by	  Marcell	  et	  al.	  did	  not	  show	  improved	  levels	  of	  C-­‐reactive	  protein	   following	   exercise	   training	   [125].	   	   This	   study	   observed	   healthy	   but	   overweight	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individuals	  over	  16	  weeks	  of	  moderate	  and	  intense	  exercise	  training.	  	  While	  the	  findings	  of	  the	  previously	  mentioned	  studies	  are	  compelling,	  they	  differ	  from	  the	  present	  study	  due	  to	  the	   fact	   that	  most	   of	   them	   observed	   changes	   following	   an	   extended	   period	   of	   time	   (i.e.,	  years).	   	  However,	   because	  HIIT	   is	   a	   newer	  mode	  of	   exercise	   training	   and	   still	   only	   short	  term,	  the	  findings	  are	  not	  as	  convincing.	  While	  we	   theorize	   that	   chronic	   inflammation	   is	   induced	   following	  HIIT,	   there	   is	   a	  lack	  of	  previous	  research	  to	  confirm	  this	  idea	  and	  the	  minimal	  literature	  on	  inflammation	  and	   HIIT	   actually	   states	   the	   opposite.	   	   A	   study	   done	   by	   Munk	   et	   al.	   observed	   post	  percutaneous	   coronary	   intervention	   patients	   and	   showed	   that	   some,	   but	   not	   all,	  inflammatory	  pathways	  were	  attenuated	  following	  HIIT	  [21].	   	  Furthermore,	  Peschel	  et	  al.	  observed	   a	   reduced	   expression	   of	   adhesion	   molecules	   in	   response	   to	   a	   high	   intensity	  training	  program	  and	  correlated	  the	  reduction	  in	  inflammatory	  markers	  to	  the	  intensity	  of	  exercise	  [126].	  	  The	  similarity	  between	  the	  aforementioned	  studies	  lies	  within	  the	  subject	  population.	  	  The	  subjects	  studied	  were	  of	  the	  cardiac	  or	  diseased	  population	  and	  they	  may	  have	   obtained	   increased	   inflammatory	   components	   prior	   to	   exercise	   training.	   	   These	  studies	   denote	   the	   need	   for	   future	   research	   with	   regards	   to	   the	   relationship	   between	  inflammation	  and	  HIIT	   in	   the	  healthy	  population.	   	  Because	   fibrinogen	   is	  more	  commonly	  being	   related	   to	   inflammation	   and	   disease	   [127],	   we	   speculate	   a	   positive	   relationship	  between	  HIIT	  and	  inflammation.	  	  We	  believe	  this	  because	  the	  subjects	  of	  the	  present	  study	  were	   apparently	   healthy	   with	   no	   contraindications	   for	   exercise	   training	   and	   not	   of	   the	  diseased	  population,	  like	  the	  studies	  mentioned	  above.	  	  Due	  to	  our	  findings	  in	  the	  present	  study,	   we	   believe	   that	   inflammation	   may	   parallel	   an	   increase	   in	   exercise	   training	   (e.g.,	  higher	  intensity	  and	  volume).	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   While	  the	  rise	   in	  fibrinogen	  levels	  observed	  in	  the	  final	   four	  weeks	  of	  this	  study	  is	  still	   important	   with	   regards	   to	   thrombosis,	   it	   is	   postulated	   that	   this	   adaptation	   did	   not	  directly	  affect	  the	  coagulation	  cascade,	  a	  hypothesis	  that	  is	  supported	  by	  the	  results	  of	  the	  clotting	  time	  analyses.	  	  Unlike	  fibrinogen,	  no	  significant	  differences	  were	  found	  with	  regard	  to	   APTT	   between	   baseline,	   4w,	   and	   8w.	   	   This	   is	   the	   first	   study	   to	   our	   knowledge	   that	  showed	  no	   changes	   in	  APTT	   following	   an	   intense	   exercise	   training	   program.	   	   Previously	  published	   articles	   showed	   APTT	   either	   increases	   [10,	   71]	   or	   decreases	   [14,	   63]	   with	  exercise	  training.	  	  With	  the	  significant	  changes	  in	  fibrinogen	  levels,	  one	  may	  expect	  to	  see	  APTT	   levels	   change	   as	   well	   because	   fibrinogen	   is	   a	   part	   of	   the	   coagulation	   cascade’s	  intrinsic	  pathway,	  which	  is	  evaluated	  during	  an	  APTT	  test.	  	  However,	  a	  change	  in	  fibrinogen	  levels	   does	   not	   always	   affect	   the	   coagulation	   cascade.	   	   As	   mentioned	   above,	   the	   rise	   in	  fibrinogen	  may	  have	  been	   through	  binding	   sites	   that	   are	  not	   involved	   in	   the	   coagulation	  cascade,	   and	   related	   to	   inflammation	   [117].	   	   This	   suggests	   that	   while	   fibrinogen	   levels	  increased	  in	  our	  subjects,	  it	  may	  not	  have	  actually	  affected	  coagulation	  activity,	  as	  APTT’s	  did	  not	  change	  over	  the	  entirety	  of	  the	  study.	  	   Similarly	  to	  APTT,	  no	  significant	  difference	  was	  found	  in	  PT	  between	  baseline,	  4w,	  and	  8w.	  	  However,	  contrary	  to	  the	  measure	  of	  APTT,	  a	  PT	  test	  does	  not	  assess	  the	  portion	  of	  the	  coagulation	  cascade	  in	  which	  fibrinogen	  plays	  a	  role.	  	  The	  fact	  that	  PT	  did	  not	  change	  throughout	  the	  training	  program	  is	  shown	  in	  the	  literature	  and	  confirmed	  with	  this	  study.	  	  Several	  investigations	  in	  the	  past	  have	  analyzed	  PT’s	  and	  shown	  that	  exercise	  training	  does	  not	   affect	   it	   [12,	  63,	  71,	  128].	   	  These	   studies	  encompassed	  different	  modes	  and	  different	  volumes	   of	   exercise	   as	   well	   as	   different	   populations	   of	   subjects.	   	   This	   finding,	   which	   is	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comparable	   to	  what	   is	   seen	   in	   the	   literature,	   suggests	   that	   the	  extrinsic	  pathway	   is	  not	  a	  modulator	  in	  the	  coagulation	  changes	  associated	  with	  exercise	  training.	  	  	   A	   limitation	   of	   this	   study	   was	   our	   subject	   population	   of	   college-­‐aged	   men.	  	  Coagulation	  parameters	  differ	  significantly	  based	  on	  the	  population	  of	  the	  cohort	  and	  our	  subject	   population	  may	  not	   be	   generalizable	   to	   the	   other	   populations.	   	   It	   is	   thought	   that	  clinical	   and	   cardiac	   populations	   that	  may	   already	   have	   an	   elevated	   inflammation	   and/or	  coagulation	   potential	   might	   experience	   something	   different	   during	   HIIT.	   	   Another	  limitation	  of	   this	  study	   lies	  within	  the	   fact	   that	  we	  did	  not	  objectively	  measure	  a	  training	  adaptation.	  	  While	  it	  is	  believed	  that	  a	  training	  adaptation	  occurred,	  no	  improvements	  were	  shown	   via	   a	   Wingate	   test.	   	   Therefore,	   future	   research	   may	   want	   to	   measure	   training	  adaptations	  via	  a	  single	  Wingate	  test	  or	  VO2	  max	  test	  before	  and	  after	  the	  training	  program.	  	  Finally,	   the	   lack	  of	   a	   non-­‐exercise	   or	   endurance	   training	   control	   group	  may	  have	   limited	  our	  ability	  to	  observe	  significant	  adaptations	  to	  HIIT.	  	  These	  groups	  were	  not	  incorporated	  because	  of	  the	  lack	  of	  available	  time	  commitment	  of	  the	  research	  team.	  Future	  research	  should	  focus	  on	  the	  goal	  to	  elucidate	  the	  volume	  of	  HIIT	  required	  to	  elicit	  beneficial	  improvements	  in	  blood	  clotting	  parameters.	  	  Specifically,	  it	  is	  important	  to	  find	   the	   volume	   and	   intensity	   of	   an	   exercise	   training	   program	   that	   yields	   the	   most	  beneficial	  values	  with	  regards	  to	   fibrinogen.	   	  Careful	   investigations	  need	  to	  be	  conducted	  with	   regards	   to	   the	   putative	   time	   course	   of	   adaptations	   and	   exercise	   intensity/volume.	  	  Several	  studies	  used	  six	  weeks	  of	  HIIT	  and	  showed	  positive	  changes	  [92,	  98],	  but	  our	  eight	  week	  study	  did	  not	  concur.	  	  It	  is	  also	  suggested	  that	  future	  investigations	  extend	  HIIT	  into	  10,	   12,	   and	   more	   weeks	   to	   analyze	   the	   occurring	   adaptations.	   	   Furthermore,	   future	  research	   should	   explore	   inflammation	   in	   response	   to	   HIIT	   including	   other	   markers	   of	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inflammation	   such	   as	   interleukin-­‐6,	   C-­‐reactive	   protein,	   interleukin-­‐1,	   and/or	   adhesion	  molecules.	  
Conclusion	  
	   In	  conclusion,	  the	  present	  study	  indicates	  that	  a	  four-­‐week	  HIIT	  program	  may	  reduce	  fibrinogen	  levels,	  but	  an	  additional	  four	  weeks	  of	  HIIT	  brought	  fibrinogen	  levels	  back	  to	  baseline	  values.	  	  It	  is	  unclear	  if	  continued	  HIIT	  would	  provoke	  further	  fibrinogen	  increases.	  	  This	  study	  elicited	  no	  change	  in	  APTT	  and	  PT	  values	  following	  four	  and	  eight	  weeks	  of	  HIIT.	  It	  is	  believed	  that	  blood	  clotting	  potential	  wasn’t	  affected	  and	  that	  fibrinogen	  changes	  were	  due	  to	  an	  inflammatory	  response.	  	  While	  fibrinogen	  is	  an	  important	  marker	  of	  blood	  clotting	  in	  the	  coagulation	  cascade,	  it	  is	  becoming	  a	  more	  important	  mediator	  of	  inflammatory	  disease	  [117].	  	  Increased	  fibrinogen	  levels	  are	  commonly	  found	  in	  cardiac	  patients,	  and	  an	  important	  risk	  factor	  for	  stroke	  [129,	  130].	  	  This	  suggests	  that,	  because	  of	  HIIT’s	  ability	  to	  induce	  inflammation,	  HIIT	  may	  be	  dangerous	  for	  those	  with	  increased	  levels	  of	  fibrinogen	  and	  should	  be	  avoided	  by	  subjects	  at	  risk.	  	  Results	  of	  this	  study	  may	  be	  important	  for	  medical	  and	  exercise	  professionals	  who	  work	  with	  individuals	  with	  elevated	  inflammation	  and	  high	  thrombotic	  risk.	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APPENDICES	  
APPENDIX	  A	  –	  Informed	  Consent	  	  
	  
Consent	  Form:	  Hemostatic	  and	  Cardiovascular	  Adaptations	  Following	  a	  High-­‐Intensity	  Interval	  Training	  Program	  in	  Healthy	  Men	  	  The	  purpose	  of	  the	  present	  study	  is	  to	  examine	  the	  effects	  of	  a	  high-­‐intensity	  interval	  training	  intervention	  on	  the	  following	  outcome	  variables	  that	  are	  independently	  associated	  with	  cardiovascular	  risk:	  (a)	  blood	  coagulation	  potential;	  (b)	  arterial	  distensibility;	  and	  (c)	  carotid	  intima	  media	  thickness.	  	  Regular	  exercise	  is	  known	  to	  improve	  various	  measures	  of	  cardiovascular	  health.	  	  Traditional	  exercise	  recommendations	  include	  doing	  20-­‐60	  minute	  bouts	  of	  continuous	  exercise,	  3-­‐5	  days	  per	  week,	  at	  a	  moderate	  intensity.	  	  New	  research	  suggests	  that	  engaging	  in	  brief,	  repeated	  bouts	  of	  high-­‐intensity	  activity	  may	  be	  as	  effective	  or	  even	  more	  effective	  than	  traditional	  exercise	  with	  regard	  to	  improving	  health	  and	  athletic	  performance.	  	  We	  are	  investigating	  whether	  this	  type	  high-­‐intensity	  interval	  training	  will	  cause	  beneficial	  changes	  related	  to	  blood	  flow,	  blood	  clotting,	  and	  the	  way	  your	  arteries	  function,	  all	  of	  which	  are	  independently	  related	  to	  risk	  of	  a	  number	  of	  chronic	  illnesses	  and	  adverse	  outcomes,	  such	  as	  heart	  attack	  and	  stroke.	  	  The	  results	  of	  this	  study	  may	  provide	  important	  information	  regarding	  the	  usefulness	  of	  a	  high-­‐intensity	  training	  program	  for	  improving	  cardiovascular	  health.	  	  	  Healthy,	  non-­‐smoking	  men	  who	  are	  between	  the	  ages	  of	  18	  and	  45	  years	  old	  and	  at	  least	  50	  kg	  (110	  lbs)	  may	  be	  eligible	  to	  participate	  in	  this	  study.	  	  Participants	  must	  have	  no	  physical	  limitations	  that	  impact	  the	  ability	  to	  exercise,	  and	  should	  not	  be	  taking	  any	  medications	  that	  may	  influence	  the	  results	  of	  the	  study.	  	  You	  may	  be	  eligible	  if	  your	  exercise	  routine	  is	  irregular,	  including	  fewer	  than	  two	  days	  a	  week	  for	  the	  previous	  three	  months.	  	  This	  study	  includes	  exercise	  training	  for	  eight	  weeks,	  three	  days	  per	  week.	  	  All	  exercise	  training	  will	  be	  done	  in	  our	  laboratory	  under	  the	  supervision	  of	  study	  personnel.	  	  Training	  sessions	  will	  begin	  with	  a	  brief	  warm-­‐up	  period,	  after	  which	  you	  would	  engage	  in	  a	  series	  of	  high-­‐intensity	  training	  bouts.	  	  Each	  bout	  will	  consist	  of	  30	  seconds	  of	  high-­‐intensity	  cycling	  followed	  by	  4.5	  minutes	  of	  easy	  walking	  or	  cycling.	  	  	  During	  the	  first	  two	  weeks,	  training	  sessions	  will	  include	  three	  bouts	  of	  cycling.	  	  With	  each	  successive	  two-­‐week	  period,	  an	  additional	  bout	  will	  be	  added	  to	  the	  session,	  so	  that	  four	  bouts	  will	  be	  done	  per	  session	  in	  weeks	  3-­‐4,	  five	  bouts	  in	  weeks	  5-­‐6,	  etc.	  	  Each	  training	  session	  is	  expected	  to	  last	  less	  than	  30	  minutes.	  	  You	  will	  be	  asked	  to	  report	  to	  the	  laboratory	  for	  data	  collection	  on	  three	  separate	  occasions.	  	  These	  visits	  will	  occur	  prior	  to	  the	  first	  week	  of	  training,	  after	  the	  4th	  week,	  and	  then	  after	  the	  eighth	  week	  of	  training.	  	  You	  should	  wear	  shorts	  and	  a	  t-­‐shirt	  for	  these	  three	  visits.	  	  Please	  avoid	  caffeine,	  exercise,	  alcohol,	  and	  nicotine	  for	  at	  least	  24	  hours	  prior	  to	  each	  data	  collection	  visit.	  	  You	  will	  also	  be	  asked	  to	  have	  fasted	  for	  the	  previous	  12	  hours.	  	  During	  data	  collection,	  we	  will	  measure	  height	  and	  weight,	  and	  then	  have	  you	  sit	  quietly	  for	  fifteen	  minutes.	  	  Resting	  heart	  rate,	  resting	  blood	  pressure,	  an	  electrocardiogram,	  ultrasound	  images	  of	  your	  femoral	  artery	  (near	  your	  groin)	  and	  carotid	  artery	  (side	  of	  your	  neck),	  and	  a	  10-­‐ml	  (<1	  Tbsp)	  blood	  sample	  will	  be	  collected	  after	  the	  seated	  rest.	  	  The	  electrocardiogram	  and	  ultrasound	  image	  will	  be	  used	  to	  determine	  cardiovascular	  risk	  factors	  such	  as	  carotid	  intima	  media	  thickness	  and	  pulse	  wave	  velocity.	  	  The	  10-­‐ml	  blood	  sample	  will	  be	  obtained	  from	  a	  vein	  in	  your	  arm	  and	  will	  be	  used	  to	  measure	  blood	  clotting	  activity.	  	  	  	  As	  with	  any	  physical	  exercise	  training,	  there	  is	  potential	  for	  prolonged	  muscle	  joint	  or	  soreness,	  and	  a	  slight	  risk	  of	  more	  serious	  muscular	  (e.g.	  muscle	  strain/sprain)	  or	  cardiovascular	  (e.g.	  heart	  attack,	  stroke)	  injury	  involved	  with	  this	  study.	  	  A	  recent	  study	  showed	  that	  this	  type	  of	  training	  was	  considered	  to	  be	  low	  risk	  for	  cardiac	  patients.	  	  Those	  high	  risk	  patients	  are	  expected	  to	  experience	  one	  overall	  adverse	  event	  in	  23,182	  hours	  of	  training.	  	  We	  expect	  the	  risk	  to	  be	  even	  lower	  for	  the	  apparently	  healthy	  participants	  in	  this	  study.	  Investigators	  will	  take	  measures	  to	  prevent	  such	  injuries,	  including	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ensuring	  adequate	  warm-­‐up	  and	  monitoring	  your	  responses	  during	  exercise.	  	  Risks	  of	  blood	  drawing	  may	  include	  discomfort,	  bruising,	  and,	  in	  rare	  cases,	  infection,	  lightheadedness,	  and	  fainting.	  	  We	  will	  use	  sterile	  procedures	  and	  trained	  personnel	  to	  ensure	  that	  there	  is	  minimal	  discomfort	  with	  obtaining	  the	  blood	  samples.	  	  Emergency	  medical	  treatment	  is	  available	  in	  the	  event	  of	  injury.	  	  You	  will	  assume	  responsibility	  for	  the	  costs	  of	  medical	  care	  that	  is	  provided.	  	  In	  the	  unlikely	  event	  of	  injury	  or	  illness	  of	  any	  kind	  as	  a	  result	  of	  participation	  in	  this	  research	  project,	  Ball	  State	  University,	  its	  agents	  and	  employees	  will	  assume	  whatever	  responsibility	  is	  required	  by	  law.	  	  	  After	  you	  complete	  the	  study,	  you	  will	  be	  given	  any	  information	  collected	  as	  part	  of	  your	  participation	  in	  this	  project.	  	  We	  also	  anticipate	  you	  will	  experience	  a	  number	  of	  health	  benefits	  from	  participating	  in	  the	  training	  program.	  	  You	  may	  also	  benefit	  from	  the	  creation	  of	  new	  scientific	  knowledge	  regarding	  future	  exercise	  recommendations	  for	  healthy	  men.	  	  Your	  participation	  in	  this	  research	  study	  is	  completely	  voluntary	  and	  you	  are	  free	  to	  withdraw	  from	  the	  study	  at	  any	  time	  for	  any	  reason	  without	  penalty	  or	  prejudice	  from	  the	  investigators.	  	  Please	  feel	  free	  to	  ask	  any	  questions	  to	  the	  investigator	  before	  signing	  this	  Informed	  Consent	  form	  and	  beginning	  the	  study,	  and	  at	  any	  time	  during	  the	  study.	  	  All	  study	  materials	  and	  information	  will	  be	  maintained	  as	  confidential.	  	  Your	  information	  will	  be	  stored	  for	  five	  years	  after	  completion	  of	  the	  study.	  	  Data	  will	  be	  stored	  in	  a	  locked	  filing	  cabinet	  in	  the	  researcher’s	  office.	  	  Electronic	  files,	  which	  will	  be	  password	  protected,	  will	  be	  stored	  on	  the	  principal	  investigator’s	  computer	  and	  preferred	  backup	  medium.	  	  If	  you	  are	  not	  eligible	  to	  participate	  in	  this	  study	  your	  information	  will	  not	  be	  retained,	  and	  will	  be	  destroyed	  by	  shredding	  paper	  files	  and	  permanently	  deleting	  electronic	  information.	  	  For	  one’s	  rights	  as	  a	  research	  subject,	  contact	  the	  Director,	  Office	  of	  Research	  Integrity,	  Ball	  State	  University,	  Muncie,	  IN,	  (765)	  285-­‐5070	  or	  the	  Institutional	  Review	  Board	  Administrator	  at	  Ball	  State	  University	  at	  irb@bsu.edu.	  	  	   **********	  	  I,	  _______________________________________________,	  agree	  to	  participate	  in	  this	  research	  project	  entitled,	  “Hemostatic	  and	  Cardiovascular	  Adaptations	  Following	  a	  High-­‐intensity	  Interval	  Training	  Program	  in	  Healthy	  Men”.	  	  I	  have	  had	  the	  study	  explained	  to	  me	  and	  my	  questions	  have	  been	  answered	  to	  my	  satisfaction.	  	  I	  have	  read	  the	  description	  of	  this	  project	  and	  give	  my	  consent	  to	  participate.	  	  I	  understand	  that	  I	  will	  receive	  a	  copy	  of	  this	  informed	  consent	  form	  to	  keep	  for	  future	  reference.	  	  ________________________________________________	  	  	  ______________________	  Participant’s	  Signature	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Date	  	  ________________________________________________	  	  	  ______________________	  Investigator’s	  Signature	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Date	  	  Paul	  R.	  Nagelkirk,	  Ph.	  D.,	  Associate	  Professor	  School	  of	  Physical	  Education,	  Sport	  &	  Exercise	  Science	  Ball	  State	  University	  Muncie,	  IN	  47306	  (756)	  285-­‐1472	  prnagelkirk@bsu.edu	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APPENDIX	  B	  –	  Health	  History	  Questionnaire	  
	  
 
Please mark all true statements: 
 
History 
You have had: 
* A heart attack 
* Heart surgery 
* Cardiac catheterization 
* Coronary angioplasty (PTCA) 
* Pacemaker/implantable cardiac 
* Defibrillator/rhythm disturbance 
* Heart valve disease 
* Heart failure 
* Heart transplantation 
* Congenital heart disease 
 
Symptoms 
* You experience chest discomfort with exertion. 
* You experience unreasonable breathlessness. 
* You experience dizziness, fainting, or blackouts. 
* You take heart medications. 
 
Other Health Issues 
* You have diabetes. 
* You have asthma or other lung disease. 
* You have burning or cramping sensation in your lower legs when walking short distances. 
* You have musculoskeletal problems that limit your physical activity. 
* You have concerns about the safety of exercise. 
* You take prescription medication(s). 
Cardiovascular Risk Factors 
* You are a man older than 45 years. 
* You smoke, or quit smoking within the previous 6 months. 
* Your blood pressure is > 140/90 mm Hg. 
* You do not know your blood pressure. 
* You take blood pressure medication. 
* Your blood cholesterol level is >200 mg/dL. 
* Your good cholesterol (HDL) is <40 mg/dl OR your bad cholesterol (LDL) is >130 mg/dl 
* You do not know your cholesterol level. 
* You have a close blood relative who had a heart attack or heart surgery before age 55 (father or brother) or 
age 65 (mother or sister). 
* You are physically inactive (i.e., you get <30 minutes of physical activity on a least 3 days per week). 
* You are >20 pounds overweight. 
* None of the above is true. 
 
Exercise History:  Briefly describe your typical exercise routine.  Specify the type (e.g. aerobic, resistance) and 
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